1692:
1073:
1534:
1438:
1330:. ILC2s promote the beiging of adipocytes, and therefore increased energy expenditure. Therefore, decreased responses of ILC2s in the tissue are a characteristic of obesity, as this interrupts their crucial role in energy homeostasis, resulting in reduced energy expenditure and increased adiposity. In addition to ILC2s, ILC1s contribute to the homeostasis of adipose tissue macrophages in both lean and obese conditions, making up 5-10% of the resident lymphocyte population, in human lean adipose depots. A high fat diet increases ILC1 number, and activation of adipose tissue, increasing IFN-γ and TNF-α levels. ILC1s produce the macrophage chemoattractant CCL2, and therefore ILC1- macrophage signalling is a key regulator of adipose tissue. This pathway could be a potential target for treating patients with
1553:. In addition, the number of ILC1s in the intestinal mucosa of patients with Crohn’s disease is increased from approximately 10% to 40% of the total ILCs present. The increase in ILCs present correlates with the severity of the disease. Evidence suggests that the plasticity between ILC3s and ILC1s in the intestine is an important factor of Crohn’s disease, with ILC3s differentiating into ILC1s when exposed to IL-12 produced by dendritic cells. However, IL-23, IL-1B and retinoic acid present in the intestine can drive the differentiation of ILC1s back to ILC3s. Evidence also suggests the ability of ILC2s to acquire the pro-inflammatory phenotype, with ILC2s producing IFN-γ present in the intestine of patients with Crohn’s disease, in response to certain environmental factors such as cytokines.
902:), critical in B and T cell development. Initially it was assumed that ID2 was required in order for CLPs to differentiate into all ILC subsets, however, research showed that knock out of ID2 during CLP development, cripples the development of all ILC subsets other than NK cell progenitors, which are not reliant on the presence of Id2. Due to this realisation, a group of lineage negative cells (requirement of any true precursor cell), that were entirely dependent on the presence of ID2, and expressed other key ILC markers, were identified, with the phenotype: Lin-ID2+IL7Ra+CD25-α4β7+, which are now known as the common helper like innate lymphoid progenitors CHILPs. They are named ‘common helper like’ due to their similarity to the T helper effector cell fates.
1643:
1499:
866:
1635:
1381:
1242:
1021:
743:
1704:(COPD) are a prototypical example of ILC plasticity. Studies in both humans and mice have shown lung resident ILC2s acquire an ILC1 phenotype during COPD, increasing IFN-γ secretion, and therefore inflammation. Various triggers, including cigarette smoke, cause secretion of IL-12 and IL-18, causing the differentiation ILC2s into ILC1s. GATA3 is down-regulated, and T-bet expression is up-regulated. Patients therefore have a higher blood ILC1:ILC2 ratio, with the abundance of ILC1s present correlating with the severity of the disease.
1084:, creating a network between the microbiota, and the host, favouring homeostasis. ILC3s restrict colonization of multiple unbeneficial bacteria in the gut, via secretion of IL-22, stimulating epithelial cells to produce antimicrobial peptides. The IL-22 production is induced due to the production of IL-23 and IL-1β by macrophages and DCs, and it promotes mucosal layer healing. For example, IL-22 can promote repair of intestinal damage after
1666:
Interestingly, it has been suggested that Th17 and Tfh inflammatory responses are generated in the gastrointestinal tract and that microbiota can increase this response. Thus the development of ILCs implicated in regulating the immune response against the microbiota in the intestine has been associated with arthritis. In case of ILC2 has an important role in regulating inflammatory responses by producing IL-4, IL-9, and IL-13.
313:
252:
376:
1688:
common feature in T cells, and it is believed this plasticity is critical to allow our immune system to fine tune responses to so many different pathogens. ILC plasticity requires cytokine receptors, their transcription factors, and access of defined chromatin regions to the transcription factors, however, it still remains unclear where these cytokines are produced and where the differentiation occurs in Vivo.
1720:
inflammatory events. Although the plasticity is reversible, during the differentiation of NKp46+ ILC3s to ILC1, the modulation of the expression of T-bet depends on IL-23, IL-2, and IL-1b and is improved by retinoic acid. Therefore, ILC3 to ILC1 plasticity depends on dendritic cells that produce these cytokines. Although the interconversion of ILC1 and ILC3 is modulated by the differential expression of
191:
767:. They are critical during both the embryonic and adult stages of development of the immune system, and therefore LTi cells are present in organs and tissues early during embryonal development. They have a pivotal role in primary and secondary lymphoid tissue organisation and in adult lymphoid tissue, regulating the adaptive immune response and maintaining secondary lymphoid tissue structures.
1003:. In the intestine, in response to a helminth infection, epithelial cells secrete high levels of IL-25, activating ILC2 cells. ILC2s produce IL-13, which drives the differentiation of additional epithelial cells, via Notch signalling pathways. This instruction allows the tissue to be remodelled to allow for the expulsion of the helminth parasite, and other large pathogens.
1453:, and viruses. These cytokines activate ILC2s, and therefore, an increased number of ILC2s, and type-2 cytokines (IL-4/5/13) are present in patients with allergic asthma. They secrete IL-13, initiating allergic lung inflammation, and additionally promote Th2 differentiation, increasing the production of IL-13, and therefore amplifying the allergic response.
1108:, promoting tolerance to beneficial commensals. The relationship between ILC3s, and T cells in the gut is therefore crucial for maintaining homeostasis, as in the absence of ILC3s, there could be uncontrolled T cell activation. In addition, microbiota play a role in fine tuning IL-22 production by ILC3s, for example, segmented filamentous bacteria in the
1653:, another inflammatory skin disease, causes epidermal thickening, forming plaques which are mainly populated with T cells and dendritic cells. The T cells portray a type 1 immune response; however, the thickening and inflammation of the epidermis is thought to be caused by the production of IL-22, IL-17A, and IL-17F by other T cells such as Th17 or
1457:
ILC2s present correlates with the severity of the disease, and evidence confirms some ‘allergen- experienced’ ILC2s persist after the resolution of the initial inflammation, portraying similarities to memory T cells. The presence of the ‘allergen- experienced’ ILC2s may be the reason asthmatic patients are often sensitised to various allergens.
1415:
vessels and airways. In addition, IL-5-producing ILC2s are found in pulmonary neuroendocrine cells in the airway branch junctions at which particles entering the airways become concentrated. The localization of ILC2 in the airways suggests that the residency of ILC2 is defined by microenvironments in different zones of the tissue.
1147:
expression of gut homing receptors on ILC1s, and ILC3s, and enhances ILC3 function, by upregulating RORγt, and IL-22. There is also crosstalk between macrophages and ILC3s, via RORγt driven GM-CSF production, that is dependent on microbial signalling, and the production of IL-1β by macrophages. A deficiency in dietary
938:. The coordinated expression of these specific transcription factors activate or repress target genes critical in the differentiation of the lymphocyte subsets. In particular, Nfil3, whose expression is regulated by cytokines, controls the differentiation of ILCs via the transcription factors Id2, RORγt, Eomes, and
1406:
of lymphocytes were identified as ILCs, most of them producing IFN-γ ILC1s. ILC3s in the oropharyngeal protect against the infection of
Candida albicans producing IL-17A and IL-17F induced by IL-23. Mice lacking ILC3s due to the deletion of RORγt or depletion suffered severe infections by Candida albicans.
734:. NCR- ILC3s mainly produce IL-17A and IL-17F, and under certain circumstances, IL-22. NCR- ILC3s can differentiate into NCR+ upon increased expression levels of T-bet. Despite expressing NK cell markers, ILC3s differ greatly from NK cells, with different developmental pathways and effector functions.
1564:
NK cells secrete IFN-γ, which has anti-tumorigenic effects. Multiple studies show a decreased frequency of NK cells and IFN-γ present in the intestine or peripheral blood of patients with intestinal cancer. Further studies are required to address their exact role in the intestinal cancer environment.
1489:
Evidence suggests that targeting ILCs may be beneficial in the design of therapeutics for autoimmune disorders. As ILCs and T cells have many redundant functions, targeting and neutralizing their effector cytokines might be a better option. Alternatively, targeting their upstream activating mediators
651:
Although considered homogenous, ILC2s can be classified into subpopulations of natural ILC2s (nILC2s), and inflammatory ILC2s (iILC2s), dependent on their responsiveness to IL-33 and IL-25. nILC2s are those responsive to IL-33 in tissues in a natural immune state, while iILC2s respond to IL-25 or the
1758:
focused on the innate system’s nonspecific nature and lack of memory. As information has emerged about the functions of NK cells and other ILCs as effectors and orchestrators of the adaptive immune response, this distinction has become less clear. Some researchers suggest that the definition should
1727:
In the case of ILC2, Gata3 can be downregulated due to the exposure of infectious agents such as the influenza virus, respiratory syncytial virus, and
Staphylococcus aureus, increasing the expression of IL12Rb2, IL-18Ra, and T-bet. The differentiation of ILC2 to ILC1 can also be reversible, although
1423:
The circadian clock and ILC interactions have been demonstrated by studying the regulation of the master gene clock Arntl. Its deletion resulted in the dysregulation of ILC3 caused by epigenetic changes, driving the expression of IL-22 and contributing to the alteration of the microbiome, epithelial
1414:
It has been shown that the ILCs can secrete neurotransmitters and neuropeptides in the lungs. ILC2s interact with neurons in the respiratory tract by the proximity to nerve fibers, and lung resident IL-5-producing ILC2s are found in collagen-rich regions close to the confluence of medium-sized blood
1308:
to induce IL-22 expression, maintaining the number of ILC3s present, and therefore intestinal homeostasis. The vitamin A metabolite, retinoic acid, also upregulates the expression of IL-22, and therefore, the absence of the AhR signalling pathway, and of retinoic acid, results in reduced immunity to
1146:
AHR ligands from diet or microbiota are recognised by immune cells, regulating ILC development and NK cell functions in the intestine. In response to tryptophan metabolites, AhR signalling maintains IL-22 expression and intestinal homeostasis. Retinoic acid, produced by dendritic cells, promotes the
1048:
In addition, ILC1s and ILC3s release oxygen radicals and lethally damaging enzymes in response to pathogenic infection, causing damage to the host tissue. The repair responses for the tissue are coordinated by the type 2 immune response, after the ILC3s and ILC1s have cleansed the tissue of microbes
1028:
In multiple tissue niches, ILCs have a relationship with non- hematopoietic cells such as stromal cells. In the lung, ILC2s have a distinct localization to stromal cells, which release IL-33, and TSLP, promoting ILC2 homeostasis, in both the steady state, and in response to helminth infection, after
1405:
The oral mucosa is colonized with commensals and is exposed to dietary antigens and pathogens. The ILCs in the oral mucosa help maintain the barrier and protect against infections. ILC3s and intraepithelial ILC1s were initially identified in tonsils and found in human gingivae. Approximately 10–15%
1392:
in both mice and humans, via epidermal Notch1 signalling. The ILC3s secrete IL-17F, which plays a role in the immune, and epithelial cellular responses during wound healing, by recruiting macrophages to the site. The expression of TNF also plays a role in wound healing as it directs localization of
1350:
proliferation, and therefore mucus production in the respiratory tract. These functions contribute to the restoration and maintenance of epithelial integrity. ILC2s provide a defence against helminth infections in the lung, via the production of AhR, IL-9, and IL-13. It is believed that these ILC2s
1191:
are the population of ILCs with the most significant anti-tumorigenic potential, with NK cells possessing the ability to recognise missing MHC Class I on the surface of tumor cells. In this way, they act in a complementary manner with the cytotoxic T cells that recognize and kill tumor cells which
982:
ILCs participate in our immune response to pathogens in all organs, in particular at mucosal surfaces. They are key in the innate immune response due to their ability to rapidly secrete immunoregulatory cytokines, however, they also play a role in the shaping of the adaptive response by interacting
725:
There are two subsets of ILC3s, NCR- and NCR+ ILC3s, with the displayed NCR on mice ILC3s being NKp46, in comparison to NKp44 displayed on human ILC3s. NKp44+ ILC3s are highly enriched in the tonsils and intestines, as an exclusive source of IL-22. Some ILC3s can also express other NK cell markers,
1665:
The ILCs have been studied in mucosal barriers and their interplay with adaptative immunity, thus implicating them with autoimmune diseases. In arthritis characterized by autoantibodies presence, the dysregulated crosstalk between Tfh and B cells has been implicated in generating those antibodies.
1232:
can also be involved in pro or anti-tumorigenic environments. The production of IL-17 can support the growth of tumors and metastasis since it induces blood vessel permeability, however, the upregulation of MHC Class II on their surface can prime CD4+ T cells, having an anti-tumorigenic effect. In
492:
between NK cells and ILC1s. Although both cell types use T-bet for development, NK cells have been found to be present in T-bet deficient hosts, but ILC1s are completely dependent on its presence. Development of NK cells is, however, completely dependent on the presence of the transcription factor
837:
Our understanding of the pathways involved in the development of ILCs has only become clear in the last few years, with our knowledge mainly based on mouse pathways. CLPs have the ability to differentiate into a number of different cell types including T cells, B cells, and ILCs, depending on the
1577:
is frequently observed in response to chronic liver inflammation, and increased proliferation of these ducts is associated with liver cancer. Evidence suggests that the enhanced proliferation is triggered by IL-13, which is produced by IL-33 induced production of ILC2 cells. ILC2s have also been
1456:
The production of IL-5 by ILC2s in the lung leads to eosinophil recruitment, and other cell populations are known to interact and shape the presence of lung ILC2s in airway inflammation in asthmatic patients. In addition, they also promote proliferation of B cells. It is believed the increase in
1068:
ILCs facilitate maintenance of barrier integrity in the intestine, protecting from various bacteria and viral infections. ILC3s are the most abundant subset present in both the adult and foetal intestine. The distribution of ILCs in the intestine changes during development, and they are unevenly
877:
including T and B cells. CILPs can then differentiate into NK cell precursors (NKP), or the more recently described common helper innate lymphoid progenitors (CHILPs). CHILPs can then differentiate into lymphoid tissue inducer progenitors (LTiPs), and innate lymphoid cell precursors (ILCPs). The
1687:
system, several studies suggest their development and phenotypic maintenance is much more complex, with a high level of plasticity between the subsets. Studies have confirmed the ability of some ILC subsets to convert into a different subset in the presence of specific cytokines. This is also a
1611:, contributing to the development of obesity. Upon dysregulation of homeostasis in the adipose tissue, the decreased responses of ILC2s are a characteristic of obesity, as this interrupts their crucial role in energy homeostasis, resulting in reduced energy expenditure, and increased adiposity.
516:
has been shown to distinguish NK cells from ILC1s. The relationship between the ILC1 and NK cell lineages still remains fuzzy due to a lack of these characteristic markers present on some NK/ILC1 cells in certain tissues, or after certain infection/inflammation events. This supports the tissue
1473:
NK cells express many cell-surface receptors that can be activating, inhibitory, adhesion, cytokine, or chemotactic. The integration of information collected through these numerous inputs allows NK cells to maintain self-tolerance and recognize self-cell stress signals. If the nuanced, dynamic
1464:
How other ILCs impact asthma is less clear, however studies show correlation between the number of IL-17 producing ILC3s, and the severity of the disease. It has been shown in mice that NK cells and ILC1s inhibit ILC2 expansion due to the production of IFN-γ, and therefore may help control the
1599:
triggers inflammation, acting on innate immune cells, including ILC1s, therefore playing an important role in the activation of an inflammatory state in the liver. Therefore, inflammation associated with obesity can influence the progression of liver disease, due to the development of insulin
1560:
due to chronic inflammation, when the ILC3s acquire the ILC1 pro-inflammatory phenotype during chronic inflammation. Since ILCs accumulate in the intestine of IBD patients, it is believed they may have a pro-tumorigenic role. Supporting this, studies show an increase in the amount of effector
1719:
The signaling induced by the cytokines governs the plasticity between ILC3 and ILC1, inducing the expression of T-bet. In patients with Crohn’s disease, the increase of ILC1 at the expense of ILC3 possibly by the production of IL-2 from T regulatory cell, leading to a pathogenic state and
750:
LTi cells are considered a separate lineage due to their unique developmental pathway, however, they are often considered to be part of the ILC3 group due to their many similar characteristics. Like ILC3s, LTi cells are dependent on RORγt. They are involved in the formation of secondary
142:(inbuilt behavioural changes following a daily cycle). Once matured, the ILCs release cytokines. The classification of ILCs is therefore based on the differences in the transcription factor and cytokine profiles associated with the development and function of the different ILC subtypes.
1424:
cells, and a disrupted uptake of lipids in the intestine. On the other hand, the deletion of Nr1d1, a protein implicated in regulating circadian metabolic responses, resulted in the reduction of NCR+ ILC3 and the increase of IL-17 production, while did not affect the LTi-like ILC3.
1711:
has been shown in vitro, and in vivo. When ILC3s are cultured with IL-2 and IL-15, it causes the up-regulation of T-bet, and the IL-12 receptor (IL-12R) β2, allowing conversion of ILC3s to ILC1s. In addition, studies suggest IL-23 can promote the conversion of ILC1s into ILC3s.
1318:
infection. Retinoic acid also enhances the expression of gut- homing markers on ILC1s, and ILC3s. Dietary nutrient availability therefore modifies the ILC immune response to infection and inflammation, highlighting the importance of a balanced and healthy diet.
1225:
produce cytokines that promote an anti-inflammatory immune response e.g. IL-13, IL-4, Amphiregulin, favouring tumor growth. However, in some settings ILC2s can produce IL-5 promoting a cytotoxic response from eosinophils and therefore an anti-tumor response.
1674:
In the case of ILC3 in multiple sclerosis, these cells have been implicated with tertiary lymphoid aggregates in the brain of patients with progressive disease. In addition, the increase of LTi-like ILC3 correlated with the autoantibodies in the brain fluid.
1069:
distributed throughout the segments of the gastro-intestinal tract. This distribution to different niches within the intestine is mediated through distinct signalling cascades. In humans, approximately 70% of the intestinal ILCs are NCR+, and 15% are NCR-.
1131:, induce IL-22 production by ILC3s. Dendritic cells can also produce IL-23 during pathogen induced stress, also activating ILC3s allowing production of IL-22. One of the mechanisms by which IL-22 regulates microbiota present in the gut is through the
965:
NK cell precursors, and ILC3 precursors have been found in the human tonsil, and foetal ILCPs present in the mouse intestine, accumulating in the Peyer’s
Patches. Retinoic acid, produced by many cell types, such as nerve cells, dendritic cells, and
1715:
There is increasing evidence indicating that ILC2s also have a certain degree of plasticity, with studies confirming their ability to convert into ILC1s and ILC3s upon exposure to specific environmental stimuli such as cytokines, or notch ligands.
1207:
to the site, creating an inflammatory environment. If successful, the recruitment of these cells will kill the tumorigenic cells, however in some cases, IFN-γ and TNF-α can play a role in the induction of immunosuppressive immune cells, such as
558:
ILC2s are tissue resident and involved in the innate response to parasites, such as helminth infection, by helping repair tissue damage. They are abundant in tissues of the skin, lung, liver, and gut. They are characterised by the production of
4523:
Heeren, A. Marijne, et al. "High and interrelated rates of PD-L1+ CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer." Cancer immunology research (2014):
990:
Since the function of ILCs is linked to their specific tissue localization, determination of the signals involved in their localization and migration patterns will be important in the identification of new avenues for treatment of diseases.
717:
and IL-23, or pathogenic signals. IL-22 is the principle cytokine produced by ILC3s and plays a fundamental role in maintaining intestinal homeostasis. However, ILC3s produce a variety of other cytokines, including IL-17, IL-22, IFN- γ, and
1249:
All ILC subsets are present in the liver and regulate the immune response to protect the tissue from viral and bacterial infection. ILC1s are the dominant ILC subset present in the liver. Their production of IFN–γ promotes the survival of
1581:
The availability of specific dietary nutrients can affect ILC immune homeostasis by altering the energy stored in the adipose tissue. Adipose tissue maintains metabolism homeostasis and is now considered a fully immunocompetent organ.
73:
Based on the difference in developmental pathways, phenotype, and signalling molecules produced, in 2013, ILCs were divided into three groups: 1, 2 and 3, however, after further investigation, they are now divided into five groups:
1032:
Lung ILC2s are positioned close to blood vessels, to allow recruitment of eosinophils from the blood. They are also positioned within the airways, where potential pathogens may accumulate. This means they are in close contact with
1695:
The ILCs present in the lungs of patients with COPD, which have the ability to convert into different ILC phenotypes, depending on the microenvironment, which can increase inflammation, contributing to the pathophysiology of the
2924:
Cupedo T, Crellin NK, Papazian N, Rombouts EJ, Weijer K, Grogan JL, et al. (January 2009). "Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells".
1460:
This allergic immune response appears to be independent of T and B cells, with evidence confirming that allergic responses that resembling asthma-like symptoms can be induced in mice that lack T and B cells, using IL-33.
986:
The strategic positioning and deep rooting of ILCs within tissues allow them to maintain homeostasis, and therefore healthy tissue functioning. However, the ILCs also have detrimental roles in different mucosal sites.
1590:
can dysregulate ILC responses via changes in dietary nutrients, having direct effects on the energy stored in the adipose tissue. Obesity is associated with changes of gastrointestinal flora, increased afflux of free
5953:
Bal SM, Bernink JH, Nagasawa M, Groot J, Shikhagaie MM, Golebski K, et al. (June 2016). "IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs".
493:
Eomes, whereas ILC1s can develop independent of its presence. This means, Eomes can generally be used as a marker for NK cells, suggesting that mature NK cells are Tbet + Eomes +, and ILC1 are Tbet + Eomes -.
1156:, and deprivation of vitamin A has been shown to enhance ILC2- mediated resistance to helminth infection in mice. ILC3s therefore form a network of interactions to maintain intestinal homeostasis, between the
983:
with other immune cells. The microenvironment of the tissue they reside in determines and fine- tunes the expression of the diverse ILC profiles, facilitating their interaction in multiple effector functions.
1151:
results in abnormally small numbers of ILC3s, and therefore a reduction of IL-22 production, and higher susceptibility to infection. Conversely, retinoic acid suppresses ILC2 proliferation by down regulating
1017:, for epithelial growth factor receptors, which facilitates differentiation of epithelial cells for tissue repair. This can function to enhance the barrier function of the epithelium and slow pathogen entry.
1474:
regulation of NK cell activation becomes unbalanced in favor of attacking self cells, autoimmune disease pathology. NK cell dysregulation has been implicated in a number of autoimmune disorders including
878:
factors present in the microenvironment determine the progression of CLPs towards specific ILC subtypes, including notch ligands, cytokines, circadian rhythm, and the expression of transcription factors.
5601:
Scordamaglia F, Balsamo M, Scordamaglia A, Moretta A, Mingari MC, Canonica GW, et al. (February 2008). "Perturbations of natural killer cell regulatory functions in respiratory allergic diseases".
3956:
Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, et al. (September 2007). "IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways".
6390:
1595:
from adipose tissue into the liver and increased gut permeability. The close anatomical proximity of the gastrointestinal tract and the liver means transportation of bacterial metabolites through the
1192:
present a foreign antigen on MHC class I. NK cells express a number of cell surface activating NK cell receptors with specificity for stress induced ligands overexpressed on tumor cells. See the
6203:
Gao Y, Souza-Fonseca-Guimaraes F, Bald T, Ng SS, Young A, Ngiow SF, et al. (September 2017). "Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells".
1393:
ILC3s to the damaged skin epidermis. In response to the release of IL-33 by the epidermis, ILC2s secrete high levels amphiregulin, a critical epidermal growth factor, therefore contributing to
1502:
The ILCs present in the nasal polyps of patients with allergic rhinitis, forming a positive feedback loop, promoting inflammation, therefore contributing to the pathophysiology of the disease.
1441:
The ILCs present in the lungs of patients with asthma, and the effector cytokines and cells involved in contributing to the pathophysiology of the disorder, by promoting a Th2 immune response.
1657:. However, more recent data suggests that ILC3s in fact produce a large number of these cytokines, with an increase in the number of ILC3s in the peripheral blood of patients with psoriasis.
1521:
ILC2s are activated due to presence of TSLP and IL-4, produced by epithelial cells and eosinophils respectively. They then produce IL-4, IL-5, and IL-13, further activating eosinophils, in a
1177:, ILC1s and ILC3s cooperate to combat the infection. ILC2s induce goblet cell differentiation, and mucus production in the intestine to protect from tissue damage upon parasitic infection.
821:, the autoimmune regulatory gene, by allowing development of embryonic thymic epithelial cells. They do this via lymphotoxin α4β7 and RANK-L signalling. LTi cells also allow the survival of
1742:
Determining the extent of ILC plasticity during disease could be useful to allow us to prevent or enhance their conversion into other subsets that may be contributing to the pathogenicity.
1525:
loop, promoting inflammation. Disrupting this loop could be a potential therapy for rhinitis. NK cells appear to play a beneficial role, with fewer present in those with allergic rhinitis.
1326:, via the production of IL-5, IL-4 and IL-13. This regulates adiposity, insulin resistance, and caloric expenditure. Dysregulation of this causes persistent type 1 inflammation, leading to
1600:
resistance and metabolic dysregulation. ILC1s as a key regulatory of adipose tissue inflammation, are therefore a potential therapeutic target for treating people with liver disease or
970:, favours the differentiation of ILC3s, rather than ILC2s, and it is required for their complete maturation. In addition, AhR, which can be triggered through ligands produced after the
2003:
Klose CS, Kiss EA, Schwierzeck V, Ebert K, Hoyler T, d'Hargues Y, et al. (February 2013). "A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells".
130:
The development of ILCs is initiated in response to the presence of transcription factors that are switched on due to the presence of surrounding microenvironmental factors, such as:
668:. iILC2s, express more KLRG1, and reduced Thy1 and ST2. In addition to these subpopulations, another population, named the ILC210 cell, is characterised by its ability to produce
1623:
than in healthy patients. The ILC2s from the skin of the patients had upregulation of the IL-25, IL-33, TSLP and PGD2 receptors, suggesting their role in the activation of ILC2s.
3864:
Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, et al. (March 2008). "Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens".
1445:
ILC2s have been confirmed to play a pathogenic role during lung inflammation. Epithelial cells in the lung express the cytokines IL-33 and IL-25, or TSLP, in response to various
461:
are up-regulated in tissues after infection or injury, and secrete TGFβ1 in tandem with IFN-γ when stimulated. This drives gut epithelial and extra-cellular matrix remodelling.
1199:
ILC1s influence the tumor microenvironment by the production of the cytokines IFN-γ and TNF-α, which at the beginning of immune response polarize other immune cells, such as
1013:
The infection can lead to tissue damage, due to migration of the helminth. ILC2s have a key role in repairing the tissue damage after infection, by producing ligands such as
3682:
Bernink JH, Peters CP, Munneke M, te Velde AA, Meijer SL, Weijer K, et al. (March 2013). "Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues".
954:
in adults, as this is where CLPs, NKPs, and CHILPs have been found. The cells then exit and circulate in the blood until they reach their designated tissues, coded for by
1384:
ILC3s and ILC2s are recruited to the wounded dermis in both mice and humans in order to aid in the healing process, by recruiting effector cells to the damaged epidermis.
962:. However, it has also been shown that the maturation of the ILCs can take place outside the primary lymphoid tissues, similar to the maturation of naïve T helper cells.
42:(immune associated), and non- lymphoid tissues, and rarely in the blood. They are particularly abundant at mucosal surfaces, playing a key role in mucosal immunity and
686:
ILC3s are involved in the innate immune response to extracellular bacteria and fungi. They play a key role in homeostasis of the intestinal bacteria and in regulating
6523:
1646:
The ILCs present in the epidermis of patients with atopic dermatitis, and the effector cells and cytokines involved in causing the pathophysiology of the disease.
1076:
ILCs and some of their key roles in the intestinal mucosa, allowing maintenance of intestinal homeostasis, via their associated cytokines and effector cells.
1573:
Hepatic ILC1s contribute to pathogenesis of chronic hepatitis B due to the production of IFN-γ, and TNF-α. Disturbance of the epithelium lining the hepatic
1006:
IL-13 also activates T cells, inducing further physiological responses to expel the parasite. T cells stimulate goblet cell mucus secretion, contraction of
1638:
The ILCs present in the epidermis of patients with psoriasis, and the effector cytokines and cells involved in causing inflammation/ epidermal thickening.
1171:, which promotes host commensalism with the local microbiota. ILC1s, and NK cells, produce IFN-γ to combat intracellular pathogens. Upon infection of
445:
Due to ILC1s and NK cells having both shared and unshared features, the classification of human ILC1s has been problematic. Both cell types produce
438:
cells. ILC1s, are non- cytotoxic or weakly cytotoxic, tissue resident cells, functioning in the defence against infections with viruses and certain
4536:"T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production"
719:
1024:
The different ILC subtypes and how they are implicated in tissue repair and regeneration after infection with oversized organs such as helminths.
802:
is another good marker for LTi cells in adult mice and humans. They can be either CD4+/-. Like ILC3s, upon activation, LTi cells mostly produce
4838:"Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-γ Secretion for Upregulating Bcl-xL Expression in Hepatocytes"
1537:
The ILCs present in the intestine of patients with IBD, and the effector cytokines and cells contributing to the pathophysiology of the disease.
999:
A fundamental property of type 2 immunity, and therefore ILC2 cells, is to deal with oversized organisms, that cannot be digested, such as the
1065:
in the bone marrow, so can directly home to the intestine, however, retinoic acid is required to allow CCR9 expression on ILC1s, and ILC3s.
512:
on human ILC1s, which is not present on all NK cells. In addition, NKp80, a marker for human NK cells, is not expressed on ILC1s. In mice,
3078:"Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells"
1759:
focus more on the germline-coding of receptors in the innate immune system versus the rearranged receptors of the adaptive immune system.
5418:
5401:
1096:
in the lumen, allowing it to be exposed to lamina propria phagocytes, leading to T cell priming. Although they can present antigens, via
648:. GATA3 is also required for maintenance of ILC2 function, with GATA3 deprivation inhibiting the development and function of the cells.
521:, although expressed by the majority of ILC1s, is absent from the salivary gland resident ILC1s, which also have the ability to express
1233:
addition, ILC3s have been reported to promote the formation of tertiary lymphoid structures in lung cancer, playing a protective role.
838:
cellular signals present. With the exception of NK cells, all ILCs require IL-7 signalling for survival. The transcriptional repressor
1731:
In certain environments, such as inflammation, chronic disease, or tumor microenvironments, activated NK cells can start to express
4109:
Macpherson AJ, Yilmaz B, Limenitakis JP, Ganal-Vonarburg SC (April 2018). "IgA Function in
Relation to the Intestinal Microbiota".
1465:
disease. Further research in human patients is required to determine how the balance between the different subsets impacts asthma.
829:, which signal to CD4+ T cells. This role could be used to prevent autoimmunity and to enhance memory responses after vaccination.
355:
6061:"Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria"
5796:"Polarization of ILC2s in peripheral blood might contribute to immunosuppressive microenvironment in patients with gastric cancer"
5637:
Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, Smith K, et al. (July 2006). "IL-23 promotes tumour incidence and growth".
3369:"AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch"
1515:
825:, and therefore memory immune responses, within newly formed lymph nodes. They do this via the TNF superfamily members OX40L and
6405:
5451:"Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity"
5110:"Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection"
1057:
Intestinal ILCs are exposed to dietary, microbial, and endogenous metabolites. ILC homing to the small intestine is mediated by
5302:"Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation"
931:
4146:"Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection"
1219:
The role of ILC2s and ILC3s in tumor surveillance is dependent on the microenvironment encountered in their resident tissues.
6437:
6295:
Bald T, Wagner M, Gao Y, Koyasu S, Smyth MJ (February 2019). "Hide and seek: Plasticity of innate lymphoid cells in cancer".
1701:
4477:"Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells"
106:, therefore they have been suggested to be the innate counterparts of T cells. The dysregulation of ILCs can lead to immune
2217:
2213:"T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow"
1792:
Spits H, Cupedo T (2012). "Innate lymphoid cells: emerging insights in development, lineage relationships, and function".
6656:
873:
ILCs are derived from common innate lymphoid progenitors (CILPs), which are derived from CLPs, which have the ability to
405:
4428:"Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells"
1490:(IL-23, IL-1B, or IL-6), or their survival factors (IL-7) could be used as an approach to treat inflammatory diseases.
1172:
38:, and the regulation of both innate and adaptive immune cells. ILCs are primarily tissue resident cells, found in both
5000:"IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation"
3821:
Ebbo M, Crinier A, Vély F, Vivier E (November 2017). "Innate lymphoid cells: major players in inflammatory diseases".
1724:
and T-bet, different questions remain that need to be explained to understand the inflammation caused by these cells.
811:
764:
710:
641:
422:
lineages diverge early in their developmental pathways and can be discriminated by their difference in dependence on
90:, and lymphoid tissue inducer (LTi) cells. ILCs are implicated in multiple physiological functions, including tissue
3909:"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells"
890:, to mediate suppression of the lymphoid cell fates generating T and B cells. It does this via reducing activity of
6692:
5402:"Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response"
4585:"Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity"
846:, yielding an ID2-dependent precursor that can further differentiate with lineage-specific transcription factors.
6339:
1209:
1038:
849:
ILCs are recombination activating gene (RAG)- independent, instead, they rely on cytokine signalling through the
1010:, and they secrete signals recruiting mast cells and eosinophils to the site, stimulating B cell proliferation.
1506:
The frequency of ILC2s has also been found to be elevated in other tissues with allergic symptoms, such as the
430:, and their resident marker expression. NK cells are cytotoxic cells, circulating in the bloodstream, killing
6615:
4378:
783:
731:
602:, which are involved in the distribution of lymphoid cells to specific organ sites. In humans, ILC2s express
59:
5847:"Natural killer cell activity for IFN-gamma production as a supportive diagnostic marker for gastric cancer"
5690:"A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses"
6737:
6707:
6687:
6248:"SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling"
4949:"Adipose Natural Killer Cells Regulate Adipose Tissue Macrophages to Promote Insulin Resistance in Obesity"
2328:"Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease"
1479:
681:
580:
482:
6246:
Cortez VS, Ulland TK, Cervantes-Barragan L, Bando JK, Robinette ML, Wang Q, et al. (September 2017).
5251:"Immunoregulatory Sensory Circuits in Group 3 Innate Lymphoid Cell (ILC3) Function and Tissue Homeostasis"
3235:"Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages"
481:
produced by both cell types also aid in the eradication of infection. ILC1s and NK cells can also produce
6725:
6720:
6560:
1794:
3274:
Xu W, Domingues RG, Fonseca-Pereira D, Ferreira M, Ribeiro H, Lopez-Lastra S, et al. (March 2015).
1365:
ILC3s are also implicated in lung infections, through the secretion of IL-17, and IL-22, for example in
1300:
ILCs play an important role in maintaining dietary stress, and metabolic homeostasis. The production of
1153:
942:. This provides evidence for the tissue signals playing a key role in fate decisions into ILC lineages.
910:
Each stage of differentiation is dependent on expression of different transcription factors, including:
791:
518:
509:
4583:
Ikutani M, Yanagibashi T, Ogasawara M, Tsuneyama K, Yamamoto S, Hattori Y, et al. (January 2012).
1578:
shown to enhance the progression of liver fibrosis, in turn promoting the development of liver cancer.
1546:
603:
508:
in both humans and mice. They also have differences in phenotypic markers, including the expression of
31:
6410:
5999:"Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity"
6430:
6395:
1305:
935:
895:
6059:
Bernink JH, Krabbendam L, Germar K, de Jong E, Gronke K, Kofoed-Nielsen M, et al. (July 2015).
3907:
Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. (September 2006).
3580:
Dahlgren MW, Jones SW, Cautivo KM, Dubinin A, Ortiz-Carpena JF, Farhat S, et al. (March 2019).
2684:"The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells"
1683:
Our classification of ILCs into subsets provides a simplified framework, however, despite the above
4204:
Wagner M, Moro K, Koyasu S (May 2017). "Plastic
Heterogeneity of Innate Lymphoid Cells in Cancer".
1957:
Walker JA, Barlow JL, McKenzie AN (February 2013). "Innate lymphoid cells--how did we miss them?".
1483:
1366:
1185:
Different groups of innate lymphoid cells have ability to influence tumorigenesis in several ways.
3320:"Identification and distribution of developing innate lymphoid cells in the fetal mouse intestine"
34:(CLPs). In response to pathogenic tissue damage, ILCs contribute to immunity via the secretion of
6764:
5501:
Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. (January 2011).
5300:
Halim TY, Steer CA, Mathä L, Gold MJ, Martinez-Gonzalez I, McNagny KM, et al. (March 2014).
4998:
Turner JE, Morrison PJ, Wilhelm C, Wilson M, Ahlfors H, Renauld JC, et al. (December 2013).
4890:
Brestoff JR, Kim BS, Saenz SA, Stine RR, Monticelli LA, Sonnenberg GF, et al. (March 2015).
4728:"NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures"
4726:
Carrega P, Loiacono F, Di Carlo E, Scaramuccia A, Mora M, Conte R, et al. (September 2015).
4000:
Ibiza S, García-Cassani B, Ribeiro H, Carvalho T, Almeida L, Marques R, et al. (July 2016).
2527:
Kim BS, Siracusa MC, Saenz SA, Noti M, Monticelli LA, Sonnenberg GF, et al. (January 2013).
2144:
Jowett GM, Norman MD, Yu TT, Rosell Arévalo P, Hoogland D, Lust ST, et al. (February 2021).
1907:
1200:
611:
135:
5739:"Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth"
2723:
Juelke K, Romagnani C (February 2016). "Differentiation of human innate lymphoid cells (ILCs)".
1212:, and therefore anti-inflammatory cytokines, allowing an immune environment the tumor cells can
1135:
patterns of epithelial cells. IL-22, and lymphotoxin expression by ILC3s controls expression of
6800:
6607:
5737:
Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, et al. (November 2012).
1755:
1359:
1310:
1259:
1116:
955:
4782:"Type 2 Innate Lymphoid Cells in Liver and Gut: From Current Knowledge to Future Perspectives"
2682:
Mjösberg J, Bernink J, Golebski K, Karrich JJ, Peters CP, Blom B, et al. (October 2012).
2578:"Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells"
2377:
Weizman OE, Adams NM, Schuster IS, Krishna C, Pritykin Y, Lau C, et al. (November 2017).
1829:
Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. (February 2013).
6646:
6623:
6599:
5200:
Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. (August 2018).
5051:"S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense"
3367:
Lee JS, Cella M, McDonald KG, Garlanda C, Kennedy GD, Nukaya M, et al. (November 2011).
2101:
Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. (August 2018).
1592:
1372:. Further studies are required to decipher the role of ILCs in human respiratory infections.
1314:
869:
Schematic diagram of the development of ILCs, mainly based on mouse differentiation pathways.
485:, further contributing to the inflammatory response, depending on their molecule expression.
218:
46:. Characteristics allowing their differentiation from other immune cells include the regular
5449:
Kim HY, Lee HJ, Chang YJ, Pichavant M, Shore SA, Fitzgerald KA, et al. (January 2014).
4287:"Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells"
4285:
Dadi S, Chhangawala S, Whitlock BM, Franklin RA, Luo CT, Oh SA, et al. (January 2016).
4060:
Goto Y, Obata T, Kunisawa J, Sato S, Ivanov II, Lamichhane A, et al. (September 2014).
2529:"TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation"
6795:
6487:
6423:
6010:
5750:
5646:
5514:
5062:
4903:
4739:
4013:
3536:
2771:
2638:
2159:
2014:
1768:
1751:
1608:
1213:
1124:
818:
638:
423:
286:
27:
4122:
2971:
Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Ivanov II, et al. (January 2009).
1807:
1254:. The production of IFN-γ by ILC1s is dependent on the expression of the NK cell receptor
465:
co-stimulation also significantly increases IFN-γ levels. The release of IFN-γ stimulates
8:
6679:
6518:
4892:"Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity"
4426:
Fuchs A, Vermi W, Lee JS, Lonardi S, Gilfillan S, Newberry RD, et al. (April 2013).
4002:"Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence"
2758:
Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F (April 2010).
1550:
1193:
1072:
1058:
1034:
1029:
the helminth has developed in the intestine, and migrated to the lung through the blood.
478:
419:
75:
6400:
6102:"Cutting Edge: Notch Signaling Promotes the Plasticity of Group-2 Innate Lymphoid Cells"
6014:
5754:
5650:
5518:
5066:
4907:
4743:
4017:
3540:
2775:
2642:
2163:
2018:
1642:
1354:
ILC1s and NK cells secrete IFN-γ in response to viral infection in the lungs, including
746:
The different phenotypic markers present on LTi cells present in an embryo and an adult.
6651:
6638:
6370:
6320:
6272:
6247:
6228:
6185:
6128:
6101:
6033:
5998:
5979:
5925:
5900:
5873:
5846:
5822:
5795:
5771:
5738:
5714:
5689:
5670:
5583:
5535:
5502:
5475:
5450:
5431:
5377:
5352:
5328:
5301:
5277:
5250:
5231:
5177:
5150:
5108:
Van Maele L, Carnoy C, Cayet D, Ivanov S, Porte R, Deruy E, et al. (August 2014).
5085:
5050:
5026:
4999:
4975:
4948:
4924:
4891:
4864:
4837:
4808:
4781:
4703:
4676:
4560:
4535:
4501:
4476:
4452:
4427:
4408:
4359:
4311:
4286:
4267:
4172:
4145:
4086:
4061:
4034:
4001:
3982:
3938:
3889:
3846:
3753:
3726:
3707:
3659:
3632:
3608:
3581:
3557:
3524:
3495:
3468:
3444:
3417:
3393:
3368:
3344:
3319:
3207:
3180:
3143:
3118:
2999:
2972:
2950:
2901:
2874:
2841:
2816:
2792:
2759:
2659:
2626:
2625:
Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, et al. (April 2010).
2602:
2577:
2553:
2528:
2504:
2477:
2405:
2378:
2354:
2327:
2292:
2265:
2241:
2212:
2211:
Daussy C, Faure F, Mayol K, Viel S, Gasteiger G, Charrier E, et al. (March 2014).
2193:
2180:
2145:
2038:
1982:
1931:
1902:
1860:
1654:
1601:
1561:
cytokines IL-23, IL-17, and IL-22, in the tumor microenvironment of intestinal cancer.
1475:
1136:
1128:
950:
Studies suggest primary site of ILC development is in the liver in the foetus, and the
850:
714:
599:
119:
3094:
3077:
2430:"Cutting edge: Salivary gland NK cells develop independently of Nfil3 in steady-state"
1351:
originate in the intestine and migrate into the lung to fight the helminth infection.
974:
food, is required for the maintenance of function and expression of intestinal ILC3s.
6702:
6583:
6502:
6482:
6362:
6324:
6312:
6277:
6220:
6189:
6177:
6133:
6082:
6038:
5971:
5930:
5878:
5827:
5776:
5719:
5688:
Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, et al. (September 2009).
5662:
5619:
5575:
5540:
5480:
5423:
5382:
5333:
5282:
5223:
5182:
5131:
5090:
5031:
4980:
4929:
4869:
4813:
4757:
4708:
4657:
4624:
Wagner M, Ealey KN, Tetsu H, Kiniwa T, Motomura Y, Moro K, Koyasu S (February 2020).
4606:
4565:
4506:
4457:
4400:
4383:
4363:
4351:
4316:
4271:
4259:
4221:
4177:
4144:
Abt MC, Lewis BB, Caballero S, Xiong H, Carter RA, Sušac B, et al. (July 2015).
4126:
4091:
4039:
3974:
3930:
3881:
3838:
3758:
3699:
3664:
3613:
3562:
3500:
3449:
3398:
3349:
3297:
3256:
3212:
3148:
3099:
3058:
3004:
2942:
2906:
2846:
2797:
2740:
2705:
2664:
2607:
2558:
2509:
2451:
2410:
2359:
2297:
2246:
2197:
2185:
2126:
2030:
1974:
1936:
1852:
1811:
1620:
1557:
1522:
1204:
6374:
6100:
Zhang K, Xu X, Pasha MA, Siebel CW, Costello A, Haczku A, et al. (March 2017).
5587:
5435:
5235:
4412:
3986:
3893:
2954:
1986:
6575:
6551:
6354:
6304:
6267:
6259:
6212:
6167:
6123:
6113:
6072:
6028:
6018:
5963:
5920:
5912:
5868:
5858:
5817:
5807:
5766:
5758:
5709:
5701:
5674:
5654:
5611:
5567:
5558:
Baxter AG, Smyth MJ (February 2002). "The role of NK cells in autoimmune disease".
5530:
5522:
5470:
5462:
5413:
5372:
5364:
5323:
5313:
5272:
5262:
5213:
5172:
5162:
5121:
5080:
5070:
5021:
5011:
4970:
4960:
4919:
4911:
4859:
4849:
4803:
4793:
4747:
4698:
4688:
4647:
4637:
4596:
4555:
4547:
4496:
4488:
4447:
4439:
4392:
4343:
4306:
4298:
4251:
4213:
4167:
4157:
4118:
4081:
4073:
4029:
4021:
3966:
3942:
3920:
3873:
3850:
3830:
3748:
3738:
3711:
3691:
3654:
3644:
3603:
3593:
3552:
3544:
3490:
3480:
3439:
3429:
3388:
3380:
3339:
3331:
3287:
3276:"NFIL3 orchestrates the emergence of common helper innate lymphoid cell precursors"
3246:
3233:
Klose CS, Flach M, Möhle L, Rogell L, Hoyler T, Ebert K, et al. (April 2014).
3202:
3192:
3138:
3130:
3089:
3048:
2994:
2984:
2934:
2896:
2886:
2836:
2828:
2787:
2779:
2732:
2695:
2654:
2646:
2597:
2589:
2548:
2540:
2499:
2489:
2441:
2400:
2390:
2349:
2339:
2287:
2277:
2236:
2226:
2175:
2167:
2150:
2116:
2042:
2022:
2005:
1966:
1926:
1916:
1864:
1842:
1803:
1732:
1628:
1168:
756:
687:
537:
446:
139:
39:
5983:
4947:
Lee BC, Kim MS, Pae M, Yamamoto Y, Eberlé D, Shimada T, et al. (April 2016).
4334:
Cerwenka A, Lanier LL (October 2001). "Natural killer cells, viruses and cancer".
2760:"Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology"
2627:"Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity"
1518:. The concentration of ILC2s positively correlates with severity of the diseases.
1498:
886:
The development of CLPs to CILPs and on to ILCs requires the transcription factor
587:. Due to their cytokine signature, they are considered the innate counterparts of
6567:
6232:
6077:
6060:
5318:
4854:
4642:
4625:
4443:
4217:
3598:
3434:
3292:
3275:
3134:
2700:
2683:
2544:
2494:
1542:
1343:
214:
55:
51:
6154:
Meininger I, Carrasco A, Rao A, Soini T, Kokkinou E, Mjösberg J (October 2020).
4242:
Wagner M, Koyasu S (May 2019). "Cancer
Immunoediting by Innate Lymphoid Cells".
2576:
Roediger B, Kyle R, Yip KH, Sumaria N, Guy TV, Kim BS, et al. (June 2013).
2478:"Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity"
6308:
6003:
Proceedings of the
National Academy of Sciences of the United States of America
5615:
5218:
5201:
4965:
4551:
4302:
4162:
3925:
3908:
3631:
Sui P, Wiesner DL, Xu J, Zhang Y, Lee J, Van Dyken S, et al. (June 2018).
3251:
3234:
2395:
2121:
2107:
2102:
1437:
1323:
1101:
1042:
1000:
807:
691:
669:
576:
572:
462:
458:
454:
399:
395:
365:
324:
320:
305:
267:
237:
226:
180:
176:
67:
5916:
5863:
5571:
3053:
3036:
2736:
2171:
1020:
759:
by promoting lymphoid tissue development, which they do through the action of
16:
Group of innate immune cells that are derived from common lymphoid progenitors
6789:
6774:
6756:
6594:
6556:
6477:
6172:
6155:
6118:
5901:"Functional interactions between innate lymphoid cells and adaptive immunity"
5845:
Lee J, Park KH, Ryu JH, Bae HJ, Choi A, Lee H, et al. (September 2017).
5368:
5267:
5167:
4693:
4601:
4584:
4492:
4255:
3743:
3582:"Adventitial Stromal Cells Define Group 2 Innate Lymphoid Cell Tissue Niches"
3485:
2891:
2446:
2429:
2344:
2282:
1921:
1331:
1132:
1105:
1007:
874:
843:
822:
771:
634:
588:
568:
564:
541:
474:
368:
347:
271:
263:
259:
95:
6023:
5526:
5419:
10.1002/(SICI)1521-4141(199803)28:03<769::AID-IMMU769>3.0.CO;2-H
5126:
5109:
5075:
5049:
Huang Y, Mao K, Chen X, Sun MA, Kawabe T, Li W, et al. (January 2018).
4836:
Nabekura T, Riggan L, Hildreth AD, O'Sullivan TE, Shibuya A (January 2020).
4677:"The Interplay Between Innate Lymphoid Cells and the Tumor Microenvironment"
4626:"Tumor-Derived Lactic Acid Contributes to the Paucity of Intratumoral ILC2s"
4381:(April 2001). "A fresh look at tumor immunosurveillance and immunotherapy".
4077:
3649:
3197:
3181:"Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology"
2973:"Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22"
2875:"Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?!"
1708:
1691:
1380:
1241:
6589:
6497:
6492:
6366:
6316:
6281:
6224:
6181:
6137:
6086:
6042:
5975:
5934:
5882:
5831:
5780:
5723:
5666:
5623:
5579:
5544:
5484:
5386:
5337:
5286:
5227:
5186:
5135:
5094:
5035:
4984:
4933:
4873:
4817:
4761:
4712:
4661:
4610:
4569:
4510:
4461:
4404:
4355:
4320:
4263:
4225:
4181:
4130:
4095:
4043:
3978:
3934:
3885:
3842:
3762:
3703:
3668:
3617:
3566:
3504:
3453:
3402:
3353:
3301:
3260:
3216:
3152:
3062:
3008:
2946:
2910:
2850:
2801:
2744:
2709:
2668:
2611:
2562:
2513:
2455:
2414:
2363:
2301:
2250:
2189:
2130:
2034:
1978:
1940:
1856:
1815:
1634:
1627:
and mast cells are also present in these skin lesions, producing IL-4, and
1583:
1286:
1143:
of epithelial cells, providing a nutrient source for the luminal bacteria.
1140:
1097:
1093:
1089:
1085:
1014:
967:
854:
560:
522:
427:
338:
290:
222:
5812:
5427:
4108:
3103:
1528:
6769:
6472:
6467:
5016:
4798:
4652:
4062:"Innate lymphoid cells regulate intestinal epithelial cell glycosylation"
2989:
2266:"T-bet and Eomesodermin in NK Cell Development, Maturation, and Function"
2231:
1596:
1507:
1347:
1278:
1274:
1258:. IL-12-driven IFN-γ production by ILC1s is accelerated by extracellular
951:
799:
760:
699:
584:
391:
331:
91:
43:
5762:
5658:
4915:
4025:
3834:
3548:
2783:
2650:
2026:
865:
6446:
4752:
4727:
3469:"Innate Lymphoid Cells in Helminth Infections-Obligatory or Accessory?"
2379:"ILC1 Confer Early Host Protection at Initial Sites of Viral Infection"
1619:
The frequency of ILC2s is higher in the inflamed skin of patients with
1355:
1301:
1251:
1164:
1157:
1120:
971:
779:
752:
694:
of the intestine, and the tonsils, however, they are also found in the
466:
99:
47:
5600:
713:
for their development and function. They express RORγt in response to
496:
ILC1s and NK cells have some phenotypic markers in common, including:
6742:
6697:
6545:
4347:
2817:"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing"
1650:
1574:
1511:
1245:
The different ILC subtypes and how they are implicated in metabolism.
1148:
959:
595:
470:
205:
198:
63:
6358:
6263:
6216:
5967:
5705:
5466:
4835:
4582:
3695:
3384:
3335:
2938:
2832:
2593:
1970:
1847:
1830:
1533:
1160:, intestinal epithelium, neuro-glial cells, and other immune cells.
6511:
6462:
6340:"Shades of grey--the blurring view of innate and adaptive immunity"
6245:
3970:
3877:
1624:
1587:
1549:
due to their increased abundance in the intestine of patients with
1446:
1282:
1112:
regulate IL-22 production and allow differentiation of Th17 cells.
881:
533:
529:
439:
208:
131:
35:
5503:"Innate or adaptive immunity? The example of natural killer cells"
4725:
4396:
3999:
3633:"Pulmonary neuroendocrine cells amplify allergic asthma responses"
3273:
544:, due to the sole production of IFN-γ without cytotoxic activity.
6730:
5794:
Bie Q, Zhang P, Su Z, Zheng D, Ying X, Wu Y, et al. (2014).
1773:
1327:
703:
513:
449:
as their principle cytokine and require the transcription factor
111:
6202:
2428:
Cortez VS, Fuchs A, Cella M, Gilfillan S, Colonna M (May 2014).
1196:
page for further information on NK cells in tumor surveillance.
1119:
to maintain intestinal homeostasis, as in response to bacteria,
1041:. Other studies also confirm the regulation of ILC function via
742:
6533:
6454:
4284:
1739:, common ILC1 markers, strengthening their plastic properties.
1541:
Research suggests IL-17 producing NCR- ILC3s contribute to the
1450:
1389:
1267:
927:
695:
661:
453:
to do so. Both cells can also produce IFN-γ when the cytokines
351:
328:
168:
115:
103:
102:, repair, and regeneration. Many of their roles are similar to
6415:
6196:
6058:
2681:
6396:
Innate lymphoid cells: major players in inflammatory diseases
2923:
1736:
1294:
1290:
1263:
1255:
1109:
1081:
923:
915:
911:
899:
891:
826:
803:
787:
665:
645:
627:
619:
615:
607:
497:
450:
435:
431:
375:
361:
312:
301:
282:
251:
241:
183:
5736:
5500:
5199:
3681:
3178:
2143:
2100:
1831:"Innate lymphoid cells--a proposal for uniform nomenclature"
1388:
Evidence shows ILC3s and ILC2s are recruited to the wounded
875:
differentiate into a number of different lymphoid cell types
4997:
3579:
2376:
1828:
1394:
1062:
919:
795:
775:
727:
657:
623:
553:
505:
501:
383:
275:
244:
87:
83:
5107:
3906:
1273:
NK cells play a role in the immune response against viral
6153:
3179:
Eberl G, Colonna M, Di Santo JP, McKenzie AN (May 2015).
2757:
2427:
2146:"ILC1 drive intestinal epithelial and matrix remodelling"
2002:
939:
887:
839:
778:, and the cytokines IL-1B, IL-23, and IL-6. They express
540:, whereas ILC1s are considered the innate counterpart of
387:
190:
6054:
6052:
5687:
5350:
4674:
3366:
2970:
234:
Large extracellular molecules (parasites and allergens)
5952:
5636:
5594:
3993:
3522:
2263:
1529:
Inflammatory bowel disease (IBD), and intestinal cancer
994:
4668:
4623:
4474:
4143:
3863:
2575:
737:
6049:
5894:
5892:
5351:
Oboki K, Nakae S, Matsumoto K, Saito H (April 2011).
4889:
4831:
4829:
4827:
4059:
3820:
3727:"Metabolic Control of Innate Lymphoid Cell Migration"
3232:
3075:
2815:
Gaffen SL, Jain R, Garg AV, Cua DJ (September 2014).
2624:
2326:
Luci C, Vieira E, Perchet T, Gual P, Golub R (2019).
2325:
1289:. They eliminate hepatic cells in fibrotic liver via
536:, NK cells are considered the innate counterparts of
6149:
6147:
5448:
5399:
4425:
4102:
3955:
2966:
2964:
2868:
2866:
2864:
2862:
2860:
2526:
2210:
1956:
1556:
Patients with IBD have an increased risk of getting
489:
6294:
6156:"Tissue-Specific Features of Innate Lymphoid Cells"
5730:
5299:
5101:
4719:
4475:Lechner MG, Liebertz DJ, Epstein AL (August 2010).
4376:
3816:
3814:
3812:
3810:
3808:
3806:
3804:
3802:
3800:
3798:
3796:
3794:
3792:
3174:
3172:
3170:
3168:
3166:
3164:
3162:
2716:
2675:
2257:
1896:
1894:
1607:ILC2s have also been identified in human and mouse
172:Intracellular microbes (virus, bacteria, parasite)
50:, absence of rearranged antigen receptors found on
6099:
5898:
5889:
5630:
4991:
4824:
3900:
3790:
3788:
3786:
3784:
3782:
3780:
3778:
3776:
3774:
3772:
3523:Palm NW, Rosenstein RK, Medzhitov R (April 2012).
3317:
3076:Mebius RE, Rennert P, Weissman IL (October 1997).
2751:
2096:
2094:
2092:
2090:
2088:
2086:
2084:
2082:
2080:
2078:
2076:
2074:
2072:
1892:
1890:
1888:
1886:
1884:
1882:
1880:
1878:
1876:
1874:
1322:ILC2s support a type- 2 immune environment in the
1262:, and IFN-γ upregulates the prosurvival molecules
905:
637:for their development, activating the fundamental
6144:
5996:
5948:
5946:
5944:
5248:
4946:
4779:
4775:
4773:
4771:
4237:
4235:
4199:
4197:
4195:
4193:
4191:
3675:
3630:
3573:
3466:
3409:
3318:Bando JK, Liang HE, Locksley RM (February 2015).
3313:
3311:
3228:
3226:
2961:
2917:
2857:
2814:
2321:
2319:
2317:
2315:
2313:
2311:
2070:
2068:
2066:
2064:
2062:
2060:
2058:
2056:
2054:
2052:
62:gene), and phenotypic markers usually present on
6787:
6239:
4203:
4055:
4053:
3159:
2370:
882:Identification of the ILC progenitor cell (ILCP)
709:ILC3s are dependent on the transcription factor
690:. Human adult ILC3s, are primarily found in the
5793:
5048:
3857:
3769:
3267:
2722:
2421:
1998:
1996:
1871:
341:, antimicrobial peptides, epithelium survival)
285:production, alternative macrophage activation,
5990:
5941:
5604:The Journal of Allergy and Clinical Immunology
5293:
4768:
4333:
4232:
4188:
3949:
3624:
3460:
3308:
3223:
3069:
3030:
3028:
3026:
3024:
3022:
3020:
3018:
2808:
2471:
2469:
2467:
2465:
2308:
2204:
2049:
1163:LTi cells are present in Peyer’s patches, and
500:in mice, and NK cell receptors (NCRs) such as
477:effect to eradicate intracellular infections.
6431:
5844:
5400:Kondo H, Ichikawa Y, Imokawa G (March 1998).
4050:
3718:
3415:
2872:
1952:
1950:
1822:
1127:, which through the neuroregulatory receptor
26:) are the most recently discovered family of
5787:
5148:
5042:
4241:
4137:
3518:
3516:
3514:
3360:
1993:
1900:
6093:
5899:Sonnenberg GF, Hepworth MR (October 2019).
5838:
5557:
5496:
5494:
5151:"Innate Lymphoid Cells in Mucosal Immunity"
4786:International Journal of Molecular Sciences
4675:Ducimetière L, Vermeer M, Tugues S (2019).
3110:
3015:
2462:
1903:"Innate Lymphoid Cells in Mucosal Immunity"
1791:
1568:
6438:
6424:
5681:
5442:
4940:
4780:Ochel A, Tiegs G, Neumann K (April 2019).
2264:Simonetta F, Pradier A, Roosnek E (2016).
1947:
1750:Historically, the distinction between the
1037:, which activate ILC2s via the release of
722:, depending on the environmental stimuli.
406:Formation of secondary lymphoid structures
6411:Innate Lymphoid Cells in Mucosal Immunity
6271:
6171:
6127:
6117:
6076:
6032:
6022:
5997:Cella M, Otero K, Colonna M (June 2010).
5924:
5872:
5862:
5821:
5811:
5770:
5713:
5534:
5474:
5417:
5376:
5357:Allergy, Asthma & Immunology Research
5327:
5317:
5276:
5266:
5217:
5176:
5166:
5125:
5084:
5074:
5025:
5015:
4974:
4964:
4923:
4863:
4853:
4807:
4797:
4751:
4702:
4692:
4651:
4641:
4600:
4559:
4500:
4451:
4310:
4171:
4161:
4085:
4033:
3924:
3752:
3742:
3724:
3658:
3648:
3607:
3597:
3556:
3511:
3494:
3484:
3443:
3433:
3392:
3343:
3291:
3250:
3206:
3196:
3142:
3093:
3052:
2998:
2988:
2900:
2890:
2840:
2791:
2699:
2658:
2601:
2552:
2503:
2493:
2445:
2404:
2394:
2353:
2343:
2291:
2281:
2240:
2230:
2179:
2120:
1930:
1920:
1846:
1180:
298:Extracellular microbes (bacteria, fungi)
6331:
5491:
5249:Domingues RG, Hepworth MR (2020-02-06).
3119:"The LTi cell, an immunologic chameleon"
1690:
1641:
1633:
1532:
1497:
1436:
1379:
1337:
1240:
1167:, interacting with B cells facilitating
1071:
1019:
864:
810:, and IL-22. They are mediated by RANK,
741:
374:
311:
250:
189:
6678:
3116:
3034:
2475:
1516:aspirin exacerbated respiratory disease
1236:
1080:ILC3s directly interact with bacterial
1061:, and the receptor CCR9. ILC2s express
945:
653:
517:specific function theory. For example,
6788:
6337:
3467:Löser S, Smith KA, Maizels RM (2019).
1104:, and therefore play a role in T cell
798:, however, no NCRs. The expression of
6419:
4885:
4883:
4123:10.1146/annurev-immunol-042617-053238
1808:10.1146/annurev-immunol-020711-075053
1745:
1728:the mechanism is not understood yet.
1709:ILC3s to convert into ILC1-like cells
1702:chronic obstructive pulmonary disease
1669:
1468:
1418:
851:common cytokine- receptor gamma chain
525:, a fundamental feature of NK cells.
5202:"Innate Lymphoid Cells: 10 Years On"
5004:The Journal of Experimental Medicine
2977:The Journal of Experimental Medicine
2218:The Journal of Experimental Medicine
2103:"Innate Lymphoid Cells: 10 Years On"
1614:
1493:
1092:. ILC3s regulate the containment of
1052:
995:Helminth infection and tissue repair
860:
6657:Mucosal associated invariant T cell
6406:NK and Innate Lymphoid Cell Biology
4533:
3416:Kotas ME, Locksley RM (June 2018).
1684:
842:appears to antagonize B and T cell
817:LTi cells induce the expression of
738:Lymphoid Tissue inducer (LTi) cells
490:dependence on transcription factors
13:
6391:Innate Lymphoid Cells: 10 Years On
5149:Panda SK, Colonna M (2019-05-07).
5114:The Journal of Infectious Diseases
4880:
1700:The ILCs present in patients with
770:Their production is stimulated by
563:, and type 2 cytokines, including
14:
6812:
6384:
1229:
1222:
1188:
125:
79:
6693:Lymphokine-activated killer cell
6445:
6288:
5551:
5393:
5353:"IL-33 and Airway Inflammation"
5344:
5242:
5193:
5142:
4617:
4576:
4527:
4517:
4468:
4419:
4370:
4327:
4278:
3037:"Lymphoid tissue inducer cells"
2618:
2569:
2520:
1039:calcitonin gene-related peptide
906:Transcription factor dependence
675:
547:
413:
5800:Journal of Immunology Research
5406:European Journal of Immunology
2533:Science Translational Medicine
2137:
1785:
1400:
1375:
1309:bacterial infections, such as
1123:in the lamina propria secrete
832:
107:
1:
3095:10.1016/S1074-7613(00)80371-4
2725:Current Opinion in Immunology
1779:
1678:
922:, GATA3, PLZF, T-bet, Eomes,
346:Mesenchymal organizer cells (
6738:Type 3 innate lymphoid cells
6726:Type 2 innate lymphoid cells
6721:Type 1 innate lymphoid cells
6708:Uterine natural killer cells
6688:Cytokine-induced killer cell
6078:10.1016/j.immuni.2015.06.019
5319:10.1016/j.immuni.2014.01.011
4855:10.1016/j.immuni.2019.11.004
4643:10.1016/j.celrep.2020.01.103
4444:10.1016/j.immuni.2013.02.010
4218:10.1016/j.trecan.2017.03.008
3599:10.1016/j.immuni.2019.02.002
3435:10.1016/j.immuni.2018.06.002
3418:"Why Innate Lymphoid Cells?"
3293:10.1016/j.celrep.2015.02.057
3135:10.1016/j.immuni.2010.11.016
2873:Pantazi E, Powell N (2019).
2701:10.1016/j.immuni.2012.08.015
2545:10.1126/scitranslmed.3005374
2495:10.1016/j.immuni.2018.05.013
1901:Panda SK, Colonna M (2019).
1660:
1631:, further activating ILC2s.
1480:systemic lupus erythematosus
1427:
682:Type 3 innate lymphoid cells
594:They express characteristic
7:
6338:Lanier LL (February 2013).
4111:Annual Review of Immunology
3117:Strober W (November 2010).
1795:Annual Review of Immunology
1762:
1360:respiratory syncytial virus
977:
32:common lymphoid progenitors
10:
6817:
6347:Nature Reviews. Immunology
6309:10.1016/j.smim.2019.04.001
5905:Nature Reviews. Immunology
5616:10.1016/j.jaci.2007.09.047
5219:10.1016/j.cell.2018.07.017
4966:10.1016/j.cmet.2016.03.002
4552:10.1016/j.cyto.2015.05.010
4336:Nature Reviews. Immunology
4303:10.1016/j.cell.2016.01.002
4163:10.1016/j.chom.2015.06.011
3926:10.1016/j.cell.2006.07.035
3823:Nature Reviews. Immunology
3252:10.1016/j.cell.2014.03.030
2821:Nature Reviews. Immunology
2396:10.1016/j.cell.2017.09.052
2122:10.1016/j.cell.2018.07.017
1959:Nature Reviews. Immunology
1835:Nature Reviews. Immunology
1409:
679:
551:
6755:
6716:
6669:
6637:
6541:
6532:
6453:
5917:10.1038/s41577-019-0194-8
5864:10.18632/oncotarget.19712
5572:10.1080/08916930290005864
3054:10.1016/j.cub.2011.03.022
2737:10.1016/j.coi.2015.11.005
2172:10.1038/s41563-020-0783-8
1510:of patients with chronic
1432:
857:pathway for development.
622:. In mice, ILC2s express
528:Due to the production of
488:There are differences in
6173:10.1016/j.it.2020.08.009
6119:10.4049/jimmunol.1601421
5369:10.4168/aair.2011.3.2.81
5268:10.3389/fimmu.2020.00116
5168:10.3389/fimmu.2019.00861
4694:10.3389/fimmu.2019.02895
4602:10.4049/jimmunol.1101270
4534:Zhu J (September 2015).
4493:10.4049/jimmunol.1000901
4256:10.1016/j.it.2019.03.004
3744:10.3389/fimmu.2019.02010
3525:"Allergic host defences"
3486:10.3389/fimmu.2019.00620
2892:10.3389/fimmu.2019.00676
2447:10.4049/jimmunol.1303469
2345:10.3389/fimmu.2019.01192
2283:10.3389/fimmu.2016.00241
1922:10.3389/fimmu.2019.00861
1569:Liver cancer and obesity
1484:type I diabetes mellitus
1306:AhR transcription factor
1115:ILC3s interact with the
1102:co-stimulatory molecules
600:receptors for chemokines
146:Immune function of ILCs
58:(due to the lack of the
6765:Hematopoietic stem cell
6524:Lymphoplasmacytoid cell
6024:10.1073/pnas.1005641107
5527:10.1126/science.1198687
5255:Frontiers in Immunology
5155:Frontiers in Immunology
5076:10.1126/science.aam5809
4681:Frontiers in Immunology
4150:Cell Host & Microbe
4078:10.1126/science.1254009
3731:Frontiers in Immunology
3650:10.1126/science.aan8546
3473:Frontiers in Immunology
3198:10.1126/science.aaa6566
3035:Withers DR (May 2011).
2879:Frontiers in Immunology
2476:Colonna M (June 2018).
2332:Frontiers in Immunology
2270:Frontiers in Immunology
1908:Frontiers in Immunology
1514:, and in patients with
1304:metabolites causes the
1203:, dendritic cells, and
894:transcription factors (
6297:Seminars in Immunology
4377:Smyth MJ, Godfrey DI,
1756:adaptive immune system
1697:
1647:
1639:
1538:
1503:
1442:
1385:
1246:
1181:Tumor microenvironment
1117:enteric nervous system
1077:
1025:
870:
747:
656:. nILC2s express more
538:cytotoxic CD8+ T cells
469:and other mononuclear
379:
316:
255:
194:
6671:Innate lymphoid cells
6647:Natural killer T cell
6106:Journal of Immunology
5127:10.1093/infdis/jiu106
4732:Nature Communications
4589:Journal of Immunology
4481:Journal of Immunology
2434:Journal of Immunology
1694:
1645:
1637:
1536:
1501:
1440:
1383:
1338:Respiratory infection
1315:Citrobacter rodentium
1244:
1100:receptors, ILCs lack
1075:
1023:
868:
745:
639:transcription factors
424:transcription factors
378:
315:
254:
219:Macrophage activation
193:
20:Innate lymphoid cells
6160:Trends in Immunology
5017:10.1084/jem.20130071
4799:10.3390/ijms20081896
4244:Trends in Immunology
3725:Willinger T (2019).
2990:10.1084/jem.20072713
2232:10.1084/jem.20131560
1769:Innate immune system
1609:white adipose tissue
1237:Liver and metabolism
1125:neurotrophic factors
1035:neuroendocrine cells
946:Origin and migration
814:, IL-17, and IL-22.
293:, thermoregulation)
287:extracellular matrix
36:signalling molecules
30:cells, derived from
6639:Innate-like T cells
6519:Transitional B cell
6015:2010PNAS..10710961C
5857:(41): 70431–70440.
5813:10.1155/2014/923135
5763:10.1038/nature11465
5755:2012Natur.491..254G
5659:10.1038/nature04808
5651:2006Natur.442..461L
5519:2011Sci...331...44V
5067:2018Sci...359..114H
4916:10.1038/nature14115
4908:2015Natur.519..242B
4744:2015NatCo...6.8280C
4636:(8): 2743–2757.e5.
4026:10.1038/nature18644
4018:2016Natur.535..440I
3835:10.1038/nri.2017.86
3549:10.1038/nature11047
3541:2012Natur.484..465P
2784:10.1038/nature08949
2776:2010Natur.464.1371B
2651:10.1038/nature08900
2643:2010Natur.464.1367N
2164:2021NatMa..20..250J
2027:10.1038/nature11813
2019:2013Natur.494..261K
1194:Natural killer cell
823:memory CD4+ T cells
688:Th17 cell responses
147:
48:lymphoid morphology
4753:10.1038/ncomms9280
3643:(6393): eaan8546.
2389:(4): 795–808.e12.
1746:Innate or adaptive
1698:
1670:Multiple sclerosis
1648:
1640:
1602:metabolic syndrome
1539:
1504:
1476:multiple sclerosis
1469:Autoimmune disease
1443:
1419:Circadian circuits
1386:
1270:, in hepatocytes.
1247:
1205:cytotoxic T cellss
1165:lymphoid follicles
1137:fucosyltransferase
1094:commensal bacteria
1078:
1026:
956:adhesion molecules
871:
763:, a member of the
748:
380:
317:
256:
195:
145:
120:autoimmune disease
6783:
6782:
6751:
6750:
6665:
6664:
6252:Nature Immunology
6205:Nature Immunology
5956:Nature Immunology
5061:(6371): 114–119.
4384:Nature Immunology
4072:(6202): 1254009.
4012:(7612): 440–443.
3959:Nature Immunology
3684:Nature Immunology
3592:(3): 707–722.e6.
3373:Nature Immunology
3324:Nature Immunology
3191:(6237): aaa6566.
2927:Nature Immunology
2637:(7293): 1367–70.
2582:Nature Immunology
1621:atopic dermatitis
1615:Skin inflammation
1558:intestinal cancer
1523:positive feedback
1494:Allergic rhinitis
1281:, limiting liver
1053:Intestinal mucosa
1043:neuronal circuits
861:Early Development
654:helminth parasite
575:, in response to
411:
410:
337:Type 3 immunity (
281:Type 2 immunity (
6808:
6703:Adaptive NK cell
6676:
6675:
6539:
6538:
6440:
6433:
6426:
6417:
6416:
6379:
6378:
6344:
6335:
6329:
6328:
6292:
6286:
6285:
6275:
6243:
6237:
6236:
6211:(9): 1004–1015.
6200:
6194:
6193:
6175:
6151:
6142:
6141:
6131:
6121:
6112:(5): 1798–1803.
6097:
6091:
6090:
6080:
6056:
6047:
6046:
6036:
6026:
5994:
5988:
5987:
5950:
5939:
5938:
5928:
5896:
5887:
5886:
5876:
5866:
5842:
5836:
5835:
5825:
5815:
5791:
5785:
5784:
5774:
5734:
5728:
5727:
5717:
5685:
5679:
5678:
5634:
5628:
5627:
5598:
5592:
5591:
5555:
5549:
5548:
5538:
5498:
5489:
5488:
5478:
5446:
5440:
5439:
5421:
5397:
5391:
5390:
5380:
5348:
5342:
5341:
5331:
5321:
5297:
5291:
5290:
5280:
5270:
5246:
5240:
5239:
5221:
5212:(5): 1054–1066.
5197:
5191:
5190:
5180:
5170:
5146:
5140:
5139:
5129:
5105:
5099:
5098:
5088:
5078:
5046:
5040:
5039:
5029:
5019:
4995:
4989:
4988:
4978:
4968:
4944:
4938:
4937:
4927:
4887:
4878:
4877:
4867:
4857:
4848:(1): 96–108.e9.
4833:
4822:
4821:
4811:
4801:
4777:
4766:
4765:
4755:
4723:
4717:
4716:
4706:
4696:
4672:
4666:
4665:
4655:
4645:
4621:
4615:
4614:
4604:
4580:
4574:
4573:
4563:
4531:
4525:
4521:
4515:
4514:
4504:
4472:
4466:
4465:
4455:
4423:
4417:
4416:
4374:
4368:
4367:
4348:10.1038/35095564
4331:
4325:
4324:
4314:
4282:
4276:
4275:
4239:
4230:
4229:
4206:Trends in Cancer
4201:
4186:
4185:
4175:
4165:
4141:
4135:
4134:
4106:
4100:
4099:
4089:
4057:
4048:
4047:
4037:
3997:
3991:
3990:
3953:
3947:
3946:
3928:
3904:
3898:
3897:
3861:
3855:
3854:
3818:
3767:
3766:
3756:
3746:
3722:
3716:
3715:
3679:
3673:
3672:
3662:
3652:
3628:
3622:
3621:
3611:
3601:
3577:
3571:
3570:
3560:
3535:(7395): 465–72.
3520:
3509:
3508:
3498:
3488:
3464:
3458:
3457:
3447:
3437:
3428:(6): 1081–1090.
3413:
3407:
3406:
3396:
3364:
3358:
3357:
3347:
3315:
3306:
3305:
3295:
3271:
3265:
3264:
3254:
3230:
3221:
3220:
3210:
3200:
3176:
3157:
3156:
3146:
3114:
3108:
3107:
3097:
3073:
3067:
3066:
3056:
3032:
3013:
3012:
3002:
2992:
2968:
2959:
2958:
2921:
2915:
2914:
2904:
2894:
2870:
2855:
2854:
2844:
2812:
2806:
2805:
2795:
2770:(7293): 1371–5.
2755:
2749:
2748:
2720:
2714:
2713:
2703:
2679:
2673:
2672:
2662:
2622:
2616:
2615:
2605:
2573:
2567:
2566:
2556:
2539:(170): 170ra16.
2524:
2518:
2517:
2507:
2497:
2488:(6): 1104–1117.
2473:
2460:
2459:
2449:
2425:
2419:
2418:
2408:
2398:
2374:
2368:
2367:
2357:
2347:
2323:
2306:
2305:
2295:
2285:
2261:
2255:
2254:
2244:
2234:
2208:
2202:
2201:
2183:
2151:Nature Materials
2141:
2135:
2134:
2124:
2115:(5): 1054–1066.
2098:
2047:
2046:
2000:
1991:
1990:
1954:
1945:
1944:
1934:
1924:
1898:
1869:
1868:
1850:
1826:
1820:
1819:
1789:
1311:gastrointestinal
1139:2, which allows
289:/tissue repair,
202:
163:Immune Function
148:
144:
140:circadian rhythm
6816:
6815:
6811:
6810:
6809:
6807:
6806:
6805:
6786:
6785:
6784:
6779:
6747:
6712:
6661:
6633:
6627:
6619:
6611:
6603:
6579:
6571:
6564:
6528:
6506:
6449:
6444:
6387:
6382:
6359:10.1038/nri3389
6342:
6336:
6332:
6293:
6289:
6264:10.1038/ni.3809
6258:(9): 995–1003.
6244:
6240:
6217:10.1038/ni.3800
6201:
6197:
6166:(10): 902–917.
6152:
6145:
6098:
6094:
6057:
6050:
6009:(24): 10961–6.
5995:
5991:
5968:10.1038/ni.3444
5951:
5942:
5911:(10): 599–613.
5897:
5890:
5843:
5839:
5792:
5788:
5749:(7423): 254–8.
5735:
5731:
5706:10.1038/nm.2015
5694:Nature Medicine
5686:
5682:
5645:(7101): 461–5.
5635:
5631:
5599:
5595:
5556:
5552:
5499:
5492:
5467:10.1038/nm.3423
5455:Nature Medicine
5447:
5443:
5398:
5394:
5349:
5345:
5298:
5294:
5247:
5243:
5198:
5194:
5147:
5143:
5106:
5102:
5047:
5043:
5010:(13): 2951–65.
4996:
4992:
4953:Cell Metabolism
4945:
4941:
4902:(7542): 242–6.
4888:
4881:
4834:
4825:
4778:
4769:
4724:
4720:
4673:
4669:
4622:
4618:
4581:
4577:
4532:
4528:
4522:
4518:
4473:
4469:
4424:
4420:
4375:
4371:
4332:
4328:
4283:
4279:
4240:
4233:
4202:
4189:
4142:
4138:
4107:
4103:
4058:
4051:
3998:
3994:
3954:
3950:
3905:
3901:
3866:Nature Medicine
3862:
3858:
3829:(11): 665–678.
3819:
3770:
3723:
3719:
3696:10.1038/ni.2534
3680:
3676:
3629:
3625:
3578:
3574:
3521:
3512:
3465:
3461:
3414:
3410:
3385:10.1038/ni.2187
3365:
3361:
3336:10.1038/ni.3057
3316:
3309:
3286:(12): 2043–54.
3272:
3268:
3231:
3224:
3177:
3160:
3115:
3111:
3074:
3070:
3041:Current Biology
3033:
3016:
2969:
2962:
2939:10.1038/ni.1668
2922:
2918:
2871:
2858:
2833:10.1038/nri3707
2813:
2809:
2756:
2752:
2721:
2717:
2680:
2676:
2623:
2619:
2594:10.1038/ni.2584
2574:
2570:
2525:
2521:
2474:
2463:
2440:(10): 4487–91.
2426:
2422:
2375:
2371:
2324:
2309:
2262:
2258:
2209:
2205:
2142:
2138:
2099:
2050:
2013:(7436): 261–5.
2001:
1994:
1971:10.1038/nri3349
1955:
1948:
1899:
1872:
1848:10.1038/nri3365
1827:
1823:
1790:
1786:
1782:
1765:
1748:
1707:The ability of
1681:
1672:
1663:
1617:
1571:
1551:Crohn’s disease
1543:pathophysiology
1531:
1496:
1471:
1435:
1430:
1421:
1412:
1403:
1397:wound healing.
1378:
1340:
1239:
1183:
1055:
997:
980:
948:
908:
884:
863:
844:differentiation
835:
765:TNF superfamily
757:Peyer’s patches
740:
684:
678:
596:surface markers
556:
550:
479:Oxygen radicals
473:, to induce an
434:-infected, and
416:
227:oxygen radicals
215:Type 1 immunity
200:
154:Tissue Signals
128:
68:dendritic cells
17:
12:
11:
5:
6814:
6804:
6803:
6798:
6781:
6780:
6778:
6777:
6772:
6767:
6761:
6759:
6753:
6752:
6749:
6748:
6746:
6745:
6740:
6735:
6734:
6733:
6723:
6717:
6714:
6713:
6711:
6710:
6705:
6700:
6695:
6690:
6684:
6682:
6673:
6667:
6666:
6663:
6662:
6660:
6659:
6654:
6649:
6643:
6641:
6635:
6634:
6632:
6631:
6630:
6629:
6625:
6621:
6617:
6613:
6609:
6605:
6601:
6592:
6587:
6577:
6569:
6562:
6554:
6548:
6542:
6536:
6530:
6529:
6527:
6526:
6521:
6516:
6515:
6514:
6504:
6500:
6495:
6490:
6485:
6480:
6475:
6470:
6465:
6459:
6457:
6451:
6450:
6443:
6442:
6435:
6428:
6420:
6414:
6413:
6408:
6403:
6398:
6393:
6386:
6385:External links
6383:
6381:
6380:
6330:
6287:
6238:
6195:
6143:
6092:
6048:
5989:
5940:
5888:
5837:
5786:
5729:
5700:(9): 1016–22.
5680:
5629:
5593:
5550:
5513:(6013): 44–9.
5490:
5441:
5392:
5343:
5292:
5241:
5192:
5141:
5120:(3): 493–503.
5100:
5041:
4990:
4939:
4879:
4823:
4767:
4718:
4667:
4616:
4575:
4526:
4516:
4487:(4): 2273–84.
4467:
4418:
4369:
4326:
4277:
4250:(5): 415–430.
4231:
4212:(5): 326–335.
4187:
4136:
4117:(1): 359–381.
4101:
4049:
3992:
3971:10.1038/ni1488
3948:
3919:(6): 1121–33.
3899:
3878:10.1038/nm1720
3856:
3768:
3717:
3674:
3623:
3572:
3510:
3459:
3408:
3359:
3307:
3266:
3245:(2): 340–356.
3222:
3158:
3109:
3088:(4): 493–504.
3068:
3047:(10): R381-2.
3014:
2960:
2916:
2856:
2827:(9): 585–600.
2807:
2750:
2715:
2674:
2617:
2568:
2519:
2461:
2420:
2369:
2307:
2256:
2203:
2158:(2): 250–259.
2136:
2048:
1992:
1946:
1870:
1821:
1783:
1781:
1778:
1777:
1776:
1771:
1764:
1761:
1747:
1744:
1685:classification
1680:
1677:
1671:
1668:
1662:
1659:
1616:
1613:
1570:
1567:
1530:
1527:
1512:rhinosinusitis
1495:
1492:
1470:
1467:
1434:
1431:
1429:
1426:
1420:
1417:
1411:
1408:
1402:
1399:
1377:
1374:
1342:ILC2s promote
1339:
1336:
1324:adipose tissue
1238:
1235:
1201:M1 macrophages
1182:
1179:
1169:IgA production
1054:
1051:
996:
993:
979:
976:
947:
944:
907:
904:
883:
880:
862:
859:
834:
831:
739:
736:
692:lamina propria
680:Main article:
677:
674:
664:, and reduced
633:ILC2s require
552:Main article:
549:
546:
542:T helper cells
415:
412:
409:
408:
403:
381:
372:
359:
343:
342:
335:
318:
309:
299:
295:
294:
279:
257:
248:
235:
231:
230:
212:
196:
187:
174:
165:
164:
161:
158:
155:
152:
127:
126:Classification
124:
15:
9:
6:
4:
3:
2:
6813:
6802:
6801:Immune system
6799:
6797:
6794:
6793:
6791:
6776:
6775:Prolymphocyte
6773:
6771:
6768:
6766:
6763:
6762:
6760:
6758:
6757:Lymphopoiesis
6754:
6744:
6741:
6739:
6736:
6732:
6729:
6728:
6727:
6724:
6722:
6719:
6718:
6715:
6709:
6706:
6704:
6701:
6699:
6696:
6694:
6691:
6689:
6686:
6685:
6683:
6681:
6677:
6674:
6672:
6668:
6658:
6655:
6653:
6650:
6648:
6645:
6644:
6642:
6640:
6636:
6628:
6622:
6620:
6614:
6612:
6606:
6604:
6598:
6597:
6596:
6595:Memory T cell
6593:
6591:
6588:
6585:
6581:
6573:
6565:
6558:
6555:
6553:
6552:Cytotoxic CD8
6549:
6547:
6544:
6543:
6540:
6537:
6535:
6531:
6525:
6522:
6520:
6517:
6513:
6510:
6509:
6508:
6501:
6499:
6496:
6494:
6491:
6489:
6488:Marginal zone
6486:
6484:
6481:
6479:
6476:
6474:
6471:
6469:
6466:
6464:
6461:
6460:
6458:
6456:
6452:
6448:
6441:
6436:
6434:
6429:
6427:
6422:
6421:
6418:
6412:
6409:
6407:
6404:
6402:
6399:
6397:
6394:
6392:
6389:
6388:
6376:
6372:
6368:
6364:
6360:
6356:
6352:
6348:
6341:
6334:
6326:
6322:
6318:
6314:
6310:
6306:
6302:
6298:
6291:
6283:
6279:
6274:
6269:
6265:
6261:
6257:
6253:
6249:
6242:
6234:
6230:
6226:
6222:
6218:
6214:
6210:
6206:
6199:
6191:
6187:
6183:
6179:
6174:
6169:
6165:
6161:
6157:
6150:
6148:
6139:
6135:
6130:
6125:
6120:
6115:
6111:
6107:
6103:
6096:
6088:
6084:
6079:
6074:
6071:(1): 146–60.
6070:
6066:
6062:
6055:
6053:
6044:
6040:
6035:
6030:
6025:
6020:
6016:
6012:
6008:
6004:
6000:
5993:
5985:
5981:
5977:
5973:
5969:
5965:
5962:(6): 636–45.
5961:
5957:
5949:
5947:
5945:
5936:
5932:
5927:
5922:
5918:
5914:
5910:
5906:
5902:
5895:
5893:
5884:
5880:
5875:
5870:
5865:
5860:
5856:
5852:
5848:
5841:
5833:
5829:
5824:
5819:
5814:
5809:
5805:
5801:
5797:
5790:
5782:
5778:
5773:
5768:
5764:
5760:
5756:
5752:
5748:
5744:
5740:
5733:
5725:
5721:
5716:
5711:
5707:
5703:
5699:
5695:
5691:
5684:
5676:
5672:
5668:
5664:
5660:
5656:
5652:
5648:
5644:
5640:
5633:
5625:
5621:
5617:
5613:
5610:(2): 479–85.
5609:
5605:
5597:
5589:
5585:
5581:
5577:
5573:
5569:
5565:
5561:
5554:
5546:
5542:
5537:
5532:
5528:
5524:
5520:
5516:
5512:
5508:
5504:
5497:
5495:
5486:
5482:
5477:
5472:
5468:
5464:
5460:
5456:
5452:
5445:
5437:
5433:
5429:
5425:
5420:
5415:
5412:(3): 769–79.
5411:
5407:
5403:
5396:
5388:
5384:
5379:
5374:
5370:
5366:
5362:
5358:
5354:
5347:
5339:
5335:
5330:
5325:
5320:
5315:
5312:(3): 425–35.
5311:
5307:
5303:
5296:
5288:
5284:
5279:
5274:
5269:
5264:
5260:
5256:
5252:
5245:
5237:
5233:
5229:
5225:
5220:
5215:
5211:
5207:
5203:
5196:
5188:
5184:
5179:
5174:
5169:
5164:
5160:
5156:
5152:
5145:
5137:
5133:
5128:
5123:
5119:
5115:
5111:
5104:
5096:
5092:
5087:
5082:
5077:
5072:
5068:
5064:
5060:
5056:
5052:
5045:
5037:
5033:
5028:
5023:
5018:
5013:
5009:
5005:
5001:
4994:
4986:
4982:
4977:
4972:
4967:
4962:
4959:(4): 685–98.
4958:
4954:
4950:
4943:
4935:
4931:
4926:
4921:
4917:
4913:
4909:
4905:
4901:
4897:
4893:
4886:
4884:
4875:
4871:
4866:
4861:
4856:
4851:
4847:
4843:
4839:
4832:
4830:
4828:
4819:
4815:
4810:
4805:
4800:
4795:
4791:
4787:
4783:
4776:
4774:
4772:
4763:
4759:
4754:
4749:
4745:
4741:
4737:
4733:
4729:
4722:
4714:
4710:
4705:
4700:
4695:
4690:
4686:
4682:
4678:
4671:
4663:
4659:
4654:
4653:11250/2763785
4649:
4644:
4639:
4635:
4631:
4627:
4620:
4612:
4608:
4603:
4598:
4595:(2): 703–13.
4594:
4590:
4586:
4579:
4571:
4567:
4562:
4557:
4553:
4549:
4545:
4541:
4537:
4530:
4520:
4512:
4508:
4503:
4498:
4494:
4490:
4486:
4482:
4478:
4471:
4463:
4459:
4454:
4449:
4445:
4441:
4438:(4): 769–81.
4437:
4433:
4429:
4422:
4414:
4410:
4406:
4402:
4398:
4397:10.1038/86297
4394:
4390:
4386:
4385:
4380:
4373:
4365:
4361:
4357:
4353:
4349:
4345:
4341:
4337:
4330:
4322:
4318:
4313:
4308:
4304:
4300:
4297:(3): 365–77.
4296:
4292:
4288:
4281:
4273:
4269:
4265:
4261:
4257:
4253:
4249:
4245:
4238:
4236:
4227:
4223:
4219:
4215:
4211:
4207:
4200:
4198:
4196:
4194:
4192:
4183:
4179:
4174:
4169:
4164:
4159:
4155:
4151:
4147:
4140:
4132:
4128:
4124:
4120:
4116:
4112:
4105:
4097:
4093:
4088:
4083:
4079:
4075:
4071:
4067:
4063:
4056:
4054:
4045:
4041:
4036:
4031:
4027:
4023:
4019:
4015:
4011:
4007:
4003:
3996:
3988:
3984:
3980:
3976:
3972:
3968:
3965:(9): 967–74.
3964:
3960:
3952:
3944:
3940:
3936:
3932:
3927:
3922:
3918:
3914:
3910:
3903:
3895:
3891:
3887:
3883:
3879:
3875:
3871:
3867:
3860:
3852:
3848:
3844:
3840:
3836:
3832:
3828:
3824:
3817:
3815:
3813:
3811:
3809:
3807:
3805:
3803:
3801:
3799:
3797:
3795:
3793:
3791:
3789:
3787:
3785:
3783:
3781:
3779:
3777:
3775:
3773:
3764:
3760:
3755:
3750:
3745:
3740:
3736:
3732:
3728:
3721:
3713:
3709:
3705:
3701:
3697:
3693:
3689:
3685:
3678:
3670:
3666:
3661:
3656:
3651:
3646:
3642:
3638:
3634:
3627:
3619:
3615:
3610:
3605:
3600:
3595:
3591:
3587:
3583:
3576:
3568:
3564:
3559:
3554:
3550:
3546:
3542:
3538:
3534:
3530:
3526:
3519:
3517:
3515:
3506:
3502:
3497:
3492:
3487:
3482:
3478:
3474:
3470:
3463:
3455:
3451:
3446:
3441:
3436:
3431:
3427:
3423:
3419:
3412:
3404:
3400:
3395:
3390:
3386:
3382:
3379:(2): 144–51.
3378:
3374:
3370:
3363:
3355:
3351:
3346:
3341:
3337:
3333:
3330:(2): 153–60.
3329:
3325:
3321:
3314:
3312:
3303:
3299:
3294:
3289:
3285:
3281:
3277:
3270:
3262:
3258:
3253:
3248:
3244:
3240:
3236:
3229:
3227:
3218:
3214:
3209:
3204:
3199:
3194:
3190:
3186:
3182:
3175:
3173:
3171:
3169:
3167:
3165:
3163:
3154:
3150:
3145:
3140:
3136:
3132:
3128:
3124:
3120:
3113:
3105:
3101:
3096:
3091:
3087:
3083:
3079:
3072:
3064:
3060:
3055:
3050:
3046:
3042:
3038:
3031:
3029:
3027:
3025:
3023:
3021:
3019:
3010:
3006:
3001:
2996:
2991:
2986:
2982:
2978:
2974:
2967:
2965:
2956:
2952:
2948:
2944:
2940:
2936:
2932:
2928:
2920:
2912:
2908:
2903:
2898:
2893:
2888:
2884:
2880:
2876:
2869:
2867:
2865:
2863:
2861:
2852:
2848:
2843:
2838:
2834:
2830:
2826:
2822:
2818:
2811:
2803:
2799:
2794:
2789:
2785:
2781:
2777:
2773:
2769:
2765:
2761:
2754:
2746:
2742:
2738:
2734:
2730:
2726:
2719:
2711:
2707:
2702:
2697:
2694:(4): 649–59.
2693:
2689:
2685:
2678:
2670:
2666:
2661:
2656:
2652:
2648:
2644:
2640:
2636:
2632:
2628:
2621:
2613:
2609:
2604:
2599:
2595:
2591:
2588:(6): 564–73.
2587:
2583:
2579:
2572:
2564:
2560:
2555:
2550:
2546:
2542:
2538:
2534:
2530:
2523:
2515:
2511:
2506:
2501:
2496:
2491:
2487:
2483:
2479:
2472:
2470:
2468:
2466:
2457:
2453:
2448:
2443:
2439:
2435:
2431:
2424:
2416:
2412:
2407:
2402:
2397:
2392:
2388:
2384:
2380:
2373:
2365:
2361:
2356:
2351:
2346:
2341:
2337:
2333:
2329:
2322:
2320:
2318:
2316:
2314:
2312:
2303:
2299:
2294:
2289:
2284:
2279:
2275:
2271:
2267:
2260:
2252:
2248:
2243:
2238:
2233:
2228:
2225:(3): 563–77.
2224:
2220:
2219:
2214:
2207:
2199:
2195:
2191:
2187:
2182:
2177:
2173:
2169:
2165:
2161:
2157:
2153:
2152:
2147:
2140:
2132:
2128:
2123:
2118:
2114:
2110:
2109:
2104:
2097:
2095:
2093:
2091:
2089:
2087:
2085:
2083:
2081:
2079:
2077:
2075:
2073:
2071:
2069:
2067:
2065:
2063:
2061:
2059:
2057:
2055:
2053:
2044:
2040:
2036:
2032:
2028:
2024:
2020:
2016:
2012:
2008:
2007:
1999:
1997:
1988:
1984:
1980:
1976:
1972:
1968:
1964:
1960:
1953:
1951:
1942:
1938:
1933:
1928:
1923:
1918:
1914:
1910:
1909:
1904:
1897:
1895:
1893:
1891:
1889:
1887:
1885:
1883:
1881:
1879:
1877:
1875:
1866:
1862:
1858:
1854:
1849:
1844:
1840:
1836:
1832:
1825:
1817:
1813:
1809:
1805:
1801:
1797:
1796:
1788:
1784:
1775:
1772:
1770:
1767:
1766:
1760:
1757:
1753:
1743:
1740:
1738:
1734:
1729:
1725:
1723:
1717:
1713:
1710:
1705:
1703:
1693:
1689:
1686:
1676:
1667:
1658:
1656:
1652:
1644:
1636:
1632:
1630:
1626:
1622:
1612:
1610:
1605:
1603:
1598:
1594:
1589:
1585:
1579:
1576:
1566:
1562:
1559:
1554:
1552:
1548:
1544:
1535:
1526:
1524:
1519:
1517:
1513:
1509:
1500:
1491:
1487:
1485:
1481:
1477:
1466:
1462:
1458:
1454:
1452:
1448:
1439:
1425:
1416:
1407:
1398:
1396:
1391:
1382:
1373:
1371:
1369:
1368:S. pneumoniae
1363:
1361:
1357:
1352:
1349:
1345:
1335:
1333:
1332:liver disease
1329:
1325:
1320:
1317:
1316:
1312:
1307:
1303:
1298:
1296:
1292:
1288:
1284:
1280:
1276:
1271:
1269:
1265:
1261:
1257:
1253:
1243:
1234:
1231:
1227:
1224:
1220:
1217:
1215:
1211:
1206:
1202:
1197:
1195:
1190:
1186:
1178:
1176:
1175:
1170:
1166:
1161:
1159:
1155:
1150:
1144:
1142:
1138:
1134:
1133:glycosylation
1130:
1126:
1122:
1118:
1113:
1111:
1107:
1103:
1099:
1095:
1091:
1087:
1083:
1074:
1070:
1066:
1064:
1060:
1059:α4β7 integrin
1050:
1046:
1044:
1040:
1036:
1030:
1022:
1018:
1016:
1011:
1009:
1008:smooth muscle
1004:
1002:
992:
988:
984:
975:
973:
969:
968:stromal cells
963:
961:
957:
953:
943:
941:
937:
934:, RORγt, and
933:
929:
925:
921:
917:
913:
903:
901:
897:
893:
889:
879:
876:
867:
858:
856:
852:
847:
845:
841:
830:
828:
824:
820:
815:
813:
809:
805:
801:
797:
793:
789:
785:
781:
777:
773:
772:retinoic acid
768:
766:
762:
758:
754:
744:
735:
733:
729:
723:
721:
716:
712:
707:
705:
701:
697:
693:
689:
683:
673:
671:
667:
663:
659:
655:
649:
647:
643:
640:
636:
631:
629:
625:
621:
617:
613:
609:
605:
601:
597:
592:
590:
586:
582:
578:
574:
570:
566:
562:
555:
545:
543:
539:
535:
531:
526:
524:
520:
515:
511:
507:
503:
499:
494:
491:
486:
484:
480:
476:
475:antimicrobial
472:
468:
464:
460:
456:
452:
448:
443:
441:
437:
433:
429:
425:
421:
407:
404:
402:
401:
397:
393:
389:
385:
382:
377:
373:
371:
370:
367:
363:
360:
357:
353:
349:
348:retinoic acid
345:
344:
340:
336:
334:
333:
330:
326:
322:
319:
314:
310:
308:
307:
303:
300:
297:
296:
292:
288:
284:
280:
278:
277:
273:
269:
265:
261:
258:
253:
249:
247:
246:
243:
239:
236:
233:
232:
228:
224:
220:
216:
213:
211:
210:
207:
203:
197:
192:
188:
186:
185:
182:
178:
175:
173:
170:
167:
166:
162:
159:
156:
153:
150:
149:
143:
141:
137:
136:notch ligands
133:
123:
121:
117:
113:
109:
105:
101:
97:
96:morphogenesis
93:
89:
85:
81:
77:
71:
69:
65:
61:
57:
53:
49:
45:
41:
37:
33:
29:
28:innate immune
25:
21:
6670:
6350:
6346:
6333:
6300:
6296:
6290:
6255:
6251:
6241:
6208:
6204:
6198:
6163:
6159:
6109:
6105:
6095:
6068:
6064:
6006:
6002:
5992:
5959:
5955:
5908:
5904:
5854:
5850:
5840:
5803:
5799:
5789:
5746:
5742:
5732:
5697:
5693:
5683:
5642:
5638:
5632:
5607:
5603:
5596:
5563:
5560:Autoimmunity
5559:
5553:
5510:
5506:
5461:(1): 54–61.
5458:
5454:
5444:
5409:
5405:
5395:
5360:
5356:
5346:
5309:
5305:
5295:
5258:
5254:
5244:
5209:
5205:
5195:
5158:
5154:
5144:
5117:
5113:
5103:
5058:
5054:
5044:
5007:
5003:
4993:
4956:
4952:
4942:
4899:
4895:
4845:
4841:
4789:
4785:
4735:
4731:
4721:
4684:
4680:
4670:
4633:
4630:Cell Reports
4629:
4619:
4592:
4588:
4578:
4546:(1): 14–24.
4543:
4539:
4529:
4524:canimm-0149.
4519:
4484:
4480:
4470:
4435:
4431:
4421:
4391:(4): 293–9.
4388:
4382:
4372:
4339:
4335:
4329:
4294:
4290:
4280:
4247:
4243:
4209:
4205:
4156:(1): 27–37.
4153:
4149:
4139:
4114:
4110:
4104:
4069:
4065:
4009:
4005:
3995:
3962:
3958:
3951:
3916:
3912:
3902:
3872:(3): 282–9.
3869:
3865:
3859:
3826:
3822:
3734:
3730:
3720:
3690:(3): 221–9.
3687:
3683:
3677:
3640:
3636:
3626:
3589:
3585:
3575:
3532:
3528:
3476:
3472:
3462:
3425:
3421:
3411:
3376:
3372:
3362:
3327:
3323:
3283:
3280:Cell Reports
3279:
3269:
3242:
3238:
3188:
3184:
3129:(5): 650–2.
3126:
3122:
3112:
3085:
3081:
3071:
3044:
3040:
2983:(1): 35–41.
2980:
2976:
2933:(1): 66–74.
2930:
2926:
2919:
2882:
2878:
2824:
2820:
2810:
2767:
2763:
2753:
2728:
2724:
2718:
2691:
2687:
2677:
2634:
2630:
2620:
2585:
2581:
2571:
2536:
2532:
2522:
2485:
2481:
2437:
2433:
2423:
2386:
2382:
2372:
2335:
2331:
2273:
2269:
2259:
2222:
2216:
2206:
2155:
2149:
2139:
2112:
2106:
2010:
2004:
1965:(2): 75–87.
1962:
1958:
1912:
1906:
1841:(2): 145–9.
1838:
1834:
1824:
1799:
1793:
1787:
1749:
1741:
1730:
1726:
1721:
1718:
1714:
1706:
1699:
1682:
1673:
1664:
1649:
1618:
1606:
1584:Malnutrition
1580:
1572:
1563:
1555:
1540:
1520:
1508:nasal polyps
1505:
1488:
1472:
1463:
1459:
1455:
1444:
1422:
1413:
1404:
1387:
1367:
1364:
1353:
1341:
1321:
1313:
1299:
1287:liver cancer
1272:
1248:
1228:
1221:
1218:
1198:
1189:Group 1 ILCs
1187:
1184:
1173:
1162:
1145:
1141:fucosylation
1114:
1098:MHC class II
1090:radiotherapy
1086:chemotherapy
1079:
1067:
1056:
1049:and debris.
1047:
1031:
1027:
1012:
1005:
998:
989:
985:
981:
964:
949:
909:
898:, E2-2, and
885:
872:
848:
836:
816:
769:
749:
724:
708:
706:, and skin.
685:
676:Group 3 ILCs
650:
632:
593:
561:amphiregulin
557:
548:Group 2 ILCs
527:
495:
487:
444:
428:cytotoxicity
417:
414:Group 1 ILCs
394:
364:
339:Phagocytosis
327:
304:
291:vasodilation
274:
240:
223:cytotoxicity
204:
179:
171:
129:
114:, bronchial
72:
23:
19:
18:
6796:Lymphocytes
6770:Lymphoblast
6468:Plasmablast
6447:Lymphocytes
6353:(2): 73–4.
5566:(1): 1–14.
5363:(2): 81–8.
4792:(8): 1896.
4738:(1): 8280.
4342:(1): 41–9.
1597:portal vein
1593:fatty acids
1401:Oral mucosa
1376:Skin repair
1348:goblet cell
1275:hepatitis B
1252:hepatocytes
1174:C. dificile
1121:glial cells
952:bone marrow
855:JAK3 kinase
833:Development
761:lymphotoxin
753:lymph nodes
700:endometrium
467:macrophages
392:Lymphotoxin
332:Lymphotoxin
92:homeostasis
44:homeostasis
6790:Categories
6584:Regulatory
6557:Helper CD4
6483:Follicular
6303:: 101273.
5851:Oncotarget
5806:: 923135.
4379:Trapani JA
1802:: 647–75.
1780:References
1679:Plasticity
1655:γδ T cells
1575:bile ducts
1356:rhinovirus
1344:epithelial
1302:tryptophan
1158:microbiome
972:catabolism
960:chemokines
774:, CXCL13,
726:including
626:, but not
471:phagocytes
160:Mediators
100:metabolism
6743:LTi cells
6698:Null cell
6546:Thymocyte
6401:Why ILCs?
6325:111390262
6190:221636264
4364:205021117
4272:119093972
2731:: 75–85.
2198:221521946
1661:Arthritis
1651:Psoriasis
1625:Basophils
1447:allergens
1428:Pathology
1395:cutaneous
1370:infection
1149:vitamin A
1001:helminths
589:Th2 cells
530:granzymes
418:ILC1 and
206:Granzymes
132:cytokines
108:pathology
6731:Nuocytes
6680:NK cells
6512:B10 cell
6375:27204420
6367:23469373
6317:30979591
6282:28759002
6225:28759001
6182:32917510
6138:28115527
6087:26187413
6065:Immunity
6043:20534450
5976:27111145
5935:31350531
5883:29050291
5832:24741632
5781:23034650
5724:19701202
5667:16688182
5624:18061653
5588:28199633
5580:11908701
5545:21212348
5485:24336249
5436:21654970
5387:21461246
5338:24613091
5306:Immunity
5287:32117267
5236:52079371
5228:30142344
5187:31134050
5136:24577508
5095:29302015
5036:24249111
4985:27050305
4934:25533952
4874:31810881
4842:Immunity
4818:30999584
4762:26395069
4713:31921156
4687:: 2895.
4662:32101749
4611:22174445
4570:26044597
4540:Cytokine
4511:20644162
4462:23453631
4432:Immunity
4413:24779449
4405:11276199
4356:11905813
4321:26806130
4264:30992189
4226:28718410
4182:26159718
4131:29400985
4096:25214634
4044:27409807
3987:21177884
3979:17581537
3935:16990136
3894:15742387
3886:18264109
3843:28804130
3763:31507605
3737:: 2010.
3704:23334791
3669:29599193
3618:30824323
3586:Immunity
3567:22538607
3505:31024526
3454:29924974
3422:Immunity
3403:22101730
3354:25501629
3302:25801035
3261:24725403
3217:25999512
3153:21094460
3123:Immunity
3082:Immunity
3063:21601793
3009:19114665
2955:22864899
2947:19029905
2911:31024537
2851:25145755
2802:20393462
2745:26707651
2710:23063330
2688:Immunity
2669:20200518
2612:23603794
2563:23363980
2514:29924976
2482:Immunity
2456:24740507
2415:29056343
2364:31191550
2338:: 1192.
2302:27379101
2251:24516120
2190:32895507
2131:30142344
2035:23334414
1987:14580303
1979:23292121
1941:31134050
1857:23348417
1816:22224763
1763:See also
1696:disease.
1588:gluttony
1283:fibrosis
978:Function
926:, RORα,
853:and the
534:perforin
440:bacteria
426:, their
209:Perforin
151:Stimuli
110:such as
76:NK cells
40:lymphoid
6534:T cells
6463:B1 cell
6455:B cells
6273:5712491
6129:5321819
6034:2890739
6011:Bibcode
5926:6982279
5874:5642566
5823:3987940
5772:3601659
5751:Bibcode
5715:3034219
5675:4431794
5647:Bibcode
5536:3089969
5515:Bibcode
5507:Science
5476:3912313
5428:9541570
5378:3062800
5329:4210641
5278:7015949
5261:: 116.
5178:6515929
5161:: 861.
5086:6956613
5063:Bibcode
5055:Science
5027:3865473
4976:4833527
4925:4447235
4904:Bibcode
4865:8108607
4809:6514972
4740:Bibcode
4704:6923277
4561:4532589
4502:2923483
4453:3634355
4312:4733424
4173:4537644
4087:4774895
4066:Science
4035:4962913
4014:Bibcode
3943:9034013
3851:2651328
3754:6713999
3712:8614680
3660:6387886
3637:Science
3609:6553479
3558:3596087
3537:Bibcode
3496:6467944
3479:: 620.
3445:6145487
3394:3468413
3345:4297560
3208:5658207
3185:Science
3144:3426921
3104:9354470
3000:2626689
2902:6460375
2885:: 676.
2842:4281037
2793:3796764
2772:Bibcode
2660:2862165
2639:Bibcode
2603:4282745
2554:3637661
2505:6344351
2406:5687850
2355:6546848
2293:4913100
2276:: 241.
2242:3949572
2181:7611574
2160:Bibcode
2043:4390857
2015:Bibcode
1932:6515929
1915:: 861.
1865:2228459
1774:NK Cell
1410:Airways
1362:(RSV).
1328:obesity
1293:and/or
704:decidua
420:NK cell
169:Tumours
112:allergy
104:T cells
64:myeloid
56:B cells
52:T cells
6478:Memory
6473:Plasma
6373:
6365:
6323:
6315:
6280:
6270:
6231:
6223:
6188:
6180:
6136:
6126:
6085:
6041:
6031:
5984:883747
5982:
5974:
5933:
5923:
5881:
5871:
5830:
5820:
5779:
5769:
5743:Nature
5722:
5712:
5673:
5665:
5639:Nature
5622:
5586:
5578:
5543:
5533:
5483:
5473:
5434:
5426:
5385:
5375:
5336:
5326:
5285:
5275:
5234:
5226:
5185:
5175:
5134:
5093:
5083:
5034:
5024:
4983:
4973:
4932:
4922:
4896:Nature
4872:
4862:
4816:
4806:
4760:
4711:
4701:
4660:
4609:
4568:
4558:
4509:
4499:
4460:
4450:
4411:
4403:
4362:
4354:
4319:
4309:
4270:
4262:
4224:
4180:
4170:
4129:
4094:
4084:
4042:
4032:
4006:Nature
3985:
3977:
3941:
3933:
3892:
3884:
3849:
3841:
3761:
3751:
3710:
3702:
3667:
3657:
3616:
3606:
3565:
3555:
3529:Nature
3503:
3493:
3452:
3442:
3401:
3391:
3352:
3342:
3300:
3259:
3215:
3205:
3151:
3141:
3102:
3061:
3007:
2997:
2953:
2945:
2909:
2899:
2849:
2839:
2800:
2790:
2764:Nature
2743:
2708:
2667:
2657:
2631:Nature
2610:
2600:
2561:
2551:
2512:
2502:
2454:
2413:
2403:
2362:
2352:
2300:
2290:
2249:
2239:
2196:
2188:
2178:
2129:
2041:
2033:
2006:Nature
1985:
1977:
1939:
1929:
1863:
1855:
1814:
1752:innate
1735:, and
1482:, and
1433:Asthma
1390:dermis
1358:, and
1285:, and
1268:Bcl-xL
1266:, and
1216:from.
1214:escape
1154:IL-7Ra
1106:anergy
928:Bcl11b
808:IL-17F
804:IL-17A
794:, and
780:c- Kit
776:RANK-L
720:GM-CSF
715:IL- 1β
696:spleen
618:, and
583:, and
571:, and
514:CD200R
483:TNF- α
356:RANK-L
352:CXCL13
329:GM-CSF
138:, and
116:asthma
6590:Naïve
6498:Pre-B
6493:Naïve
6371:S2CID
6343:(PDF)
6321:S2CID
6233:30239
6229:S2CID
6186:S2CID
5980:S2CID
5671:S2CID
5584:S2CID
5432:S2CID
5232:S2CID
4409:S2CID
4360:S2CID
4268:S2CID
3983:S2CID
3939:S2CID
3890:S2CID
3847:S2CID
3708:S2CID
2951:S2CID
2194:S2CID
2039:S2CID
1983:S2CID
1861:S2CID
1737:CXCR6
1733:CD49a
1722:RORγt
1451:fungi
1295:NKG2D
1291:TRAIL
1264:Bcl-2
1256:CD226
1230:ILC3s
1223:ILC2s
1210:MDSCs
1110:ileum
1082:flora
924:RUNX3
916:TCF-1
912:NFIL3
892:E-box
827:CD30L
800:OX40L
792:CD127
728:NKp30
711:RORγt
670:IL-10
666:KLRG1
646:GATA3
628:CD161
616:CD161
608:KLRG1
604:CRTH2
585:IL-33
577:IL-25
573:IL-13
523:Eomes
519:CD127
510:CD127
506:NKp46
502:NKp44
498:NK1.1
463:IL-18
459:IL-12
455:IL-15
451:T-bet
447:IFN-γ
436:tumor
432:virus
400:IL-22
396:IL-17
366:IL-23
362:IL-1B
325:IL-17
321:IL-22
306:IL-23
302:IL-1B
283:Mucus
268:IL-13
242:IL-33
238:IL-25
184:IL-1B
181:IL-15
177:IL-12
157:Cell
88:ILC3s
84:ILC2s
80:ILC1s
6550:αβ (
6507:cell
6363:PMID
6313:PMID
6278:PMID
6221:PMID
6178:PMID
6134:PMID
6083:PMID
6039:PMID
5972:PMID
5931:PMID
5879:PMID
5828:PMID
5804:2014
5777:PMID
5720:PMID
5663:PMID
5620:PMID
5576:PMID
5541:PMID
5481:PMID
5424:PMID
5383:PMID
5334:PMID
5283:PMID
5224:PMID
5206:Cell
5183:PMID
5132:PMID
5091:PMID
5032:PMID
4981:PMID
4930:PMID
4870:PMID
4814:PMID
4758:PMID
4709:PMID
4658:PMID
4607:PMID
4566:PMID
4507:PMID
4458:PMID
4401:PMID
4352:PMID
4317:PMID
4291:Cell
4260:PMID
4222:PMID
4178:PMID
4127:PMID
4092:PMID
4040:PMID
3975:PMID
3931:PMID
3913:Cell
3882:PMID
3839:PMID
3759:PMID
3700:PMID
3665:PMID
3614:PMID
3563:PMID
3501:PMID
3450:PMID
3399:PMID
3350:PMID
3298:PMID
3257:PMID
3239:Cell
3213:PMID
3149:PMID
3100:PMID
3059:PMID
3005:PMID
2943:PMID
2907:PMID
2847:PMID
2798:PMID
2741:PMID
2706:PMID
2665:PMID
2608:PMID
2559:PMID
2510:PMID
2452:PMID
2411:PMID
2383:Cell
2360:PMID
2298:PMID
2247:PMID
2186:PMID
2127:PMID
2108:Cell
2031:PMID
1975:PMID
1937:PMID
1853:PMID
1812:PMID
1754:and
1629:PGD2
1586:and
1346:and
1277:and
1063:CCR9
1015:AREG
958:and
932:Gfi1
920:ETS1
819:AIRE
796:CD90
788:CD25
784:CCR6
755:and
732:CD56
730:and
660:and
658:Thy1
644:and
642:RORα
635:IL-7
624:CD44
620:CD25
612:SST2
598:and
581:TSLP
569:IL-5
565:IL-4
554:ILC2
532:and
504:and
384:RANK
369:IL-6
276:AREG
272:IL-9
264:IL-5
260:IL-4
245:TSLP
199:IFN-
118:and
54:and
24:ILCs
6505:reg
6355:doi
6305:doi
6268:PMC
6260:doi
6213:doi
6168:doi
6124:PMC
6114:doi
6110:198
6073:doi
6029:PMC
6019:doi
6007:107
5964:doi
5921:PMC
5913:doi
5869:PMC
5859:doi
5818:PMC
5808:doi
5767:PMC
5759:doi
5747:491
5710:PMC
5702:doi
5655:doi
5643:442
5612:doi
5608:121
5568:doi
5531:PMC
5523:doi
5511:331
5471:PMC
5463:doi
5414:doi
5373:PMC
5365:doi
5324:PMC
5314:doi
5273:PMC
5263:doi
5214:doi
5210:174
5173:PMC
5163:doi
5122:doi
5118:210
5081:PMC
5071:doi
5059:359
5022:PMC
5012:doi
5008:210
4971:PMC
4961:doi
4920:PMC
4912:doi
4900:519
4860:PMC
4850:doi
4804:PMC
4794:doi
4748:doi
4699:PMC
4689:doi
4648:hdl
4638:doi
4597:doi
4593:188
4556:PMC
4548:doi
4497:PMC
4489:doi
4485:185
4448:PMC
4440:doi
4393:doi
4344:doi
4307:PMC
4299:doi
4295:164
4252:doi
4214:doi
4168:PMC
4158:doi
4119:doi
4082:PMC
4074:doi
4070:345
4030:PMC
4022:doi
4010:535
3967:doi
3921:doi
3917:126
3874:doi
3831:doi
3749:PMC
3739:doi
3692:doi
3655:PMC
3645:doi
3641:360
3604:PMC
3594:doi
3553:PMC
3545:doi
3533:484
3491:PMC
3481:doi
3440:PMC
3430:doi
3389:PMC
3381:doi
3340:PMC
3332:doi
3288:doi
3247:doi
3243:157
3203:PMC
3193:doi
3189:348
3139:PMC
3131:doi
3090:doi
3049:doi
2995:PMC
2985:doi
2981:206
2935:doi
2897:PMC
2887:doi
2837:PMC
2829:doi
2788:PMC
2780:doi
2768:464
2733:doi
2696:doi
2655:PMC
2647:doi
2635:464
2598:PMC
2590:doi
2549:PMC
2541:doi
2500:PMC
2490:doi
2442:doi
2438:192
2401:PMC
2391:doi
2387:171
2350:PMC
2340:doi
2288:PMC
2278:doi
2237:PMC
2227:doi
2223:211
2176:PMC
2168:doi
2117:doi
2113:174
2023:doi
2011:494
1967:doi
1927:PMC
1917:doi
1843:doi
1804:doi
1547:IBD
1545:of
1260:ATP
1129:RET
1088:or
940:Tox
936:AhR
900:HEB
896:E2A
888:ID2
840:ID2
812:TNF
662:ST2
457:or
388:TNF
66:or
60:RAG
6792::
6652:γδ
6626:VM
6618:RM
6610:EM
6602:CM
6582:/
6580:17
6574:/
6566:/
6563:FH
6559:/
6369:.
6361:.
6351:13
6349:.
6345:.
6319:.
6311:.
6301:41
6299:.
6276:.
6266:.
6256:18
6254:.
6250:.
6227:.
6219:.
6209:18
6207:.
6184:.
6176:.
6164:41
6162:.
6158:.
6146:^
6132:.
6122:.
6108:.
6104:.
6081:.
6069:43
6067:.
6063:.
6051:^
6037:.
6027:.
6017:.
6005:.
6001:.
5978:.
5970:.
5960:17
5958:.
5943:^
5929:.
5919:.
5909:19
5907:.
5903:.
5891:^
5877:.
5867:.
5853:.
5849:.
5826:.
5816:.
5802:.
5798:.
5775:.
5765:.
5757:.
5745:.
5741:.
5718:.
5708:.
5698:15
5696:.
5692:.
5669:.
5661:.
5653:.
5641:.
5618:.
5606:.
5582:.
5574:.
5564:35
5562:.
5539:.
5529:.
5521:.
5509:.
5505:.
5493:^
5479:.
5469:.
5459:20
5457:.
5453:.
5430:.
5422:.
5410:28
5408:.
5404:.
5381:.
5371:.
5359:.
5355:.
5332:.
5322:.
5310:40
5308:.
5304:.
5281:.
5271:.
5259:11
5257:.
5253:.
5230:.
5222:.
5208:.
5204:.
5181:.
5171:.
5159:10
5157:.
5153:.
5130:.
5116:.
5112:.
5089:.
5079:.
5069:.
5057:.
5053:.
5030:.
5020:.
5006:.
5002:.
4979:.
4969:.
4957:23
4955:.
4951:.
4928:.
4918:.
4910:.
4898:.
4894:.
4882:^
4868:.
4858:.
4846:52
4844:.
4840:.
4826:^
4812:.
4802:.
4790:20
4788:.
4784:.
4770:^
4756:.
4746:.
4734:.
4730:.
4707:.
4697:.
4685:10
4683:.
4679:.
4656:.
4646:.
4634:30
4632:.
4628:.
4605:.
4591:.
4587:.
4564:.
4554:.
4544:75
4542:.
4538:.
4505:.
4495:.
4483:.
4479:.
4456:.
4446:.
4436:38
4434:.
4430:.
4407:.
4399:.
4387:.
4358:.
4350:.
4338:.
4315:.
4305:.
4293:.
4289:.
4266:.
4258:.
4248:40
4246:.
4234:^
4220:.
4208:.
4190:^
4176:.
4166:.
4154:18
4152:.
4148:.
4125:.
4115:36
4113:.
4090:.
4080:.
4068:.
4064:.
4052:^
4038:.
4028:.
4020:.
4008:.
4004:.
3981:.
3973:.
3961:.
3937:.
3929:.
3915:.
3911:.
3888:.
3880:.
3870:14
3868:.
3845:.
3837:.
3827:17
3825:.
3771:^
3757:.
3747:.
3735:10
3733:.
3729:.
3706:.
3698:.
3688:14
3686:.
3663:.
3653:.
3639:.
3635:.
3612:.
3602:.
3590:50
3588:.
3584:.
3561:.
3551:.
3543:.
3531:.
3527:.
3513:^
3499:.
3489:.
3477:10
3475:.
3471:.
3448:.
3438:.
3426:48
3424:.
3420:.
3397:.
3387:.
3377:13
3375:.
3371:.
3348:.
3338:.
3328:16
3326:.
3322:.
3310:^
3296:.
3284:10
3282:.
3278:.
3255:.
3241:.
3237:.
3225:^
3211:.
3201:.
3187:.
3183:.
3161:^
3147:.
3137:.
3127:33
3125:.
3121:.
3098:.
3084:.
3080:.
3057:.
3045:21
3043:.
3039:.
3017:^
3003:.
2993:.
2979:.
2975:.
2963:^
2949:.
2941:.
2931:10
2929:.
2905:.
2895:.
2883:10
2881:.
2877:.
2859:^
2845:.
2835:.
2825:14
2823:.
2819:.
2796:.
2786:.
2778:.
2766:.
2762:.
2739:.
2729:38
2727:.
2704:.
2692:37
2690:.
2686:.
2663:.
2653:.
2645:.
2633:.
2629:.
2606:.
2596:.
2586:14
2584:.
2580:.
2557:.
2547:.
2535:.
2531:.
2508:.
2498:.
2486:48
2484:.
2480:.
2464:^
2450:.
2436:.
2432:.
2409:.
2399:.
2385:.
2381:.
2358:.
2348:.
2336:10
2334:.
2330:.
2310:^
2296:.
2286:.
2272:.
2268:.
2245:.
2235:.
2221:.
2215:.
2192:.
2184:.
2174:.
2166:.
2156:20
2154:.
2148:.
2125:.
2111:.
2105:.
2051:^
2037:.
2029:.
2021:.
2009:.
1995:^
1981:.
1973:.
1963:13
1961:.
1949:^
1935:.
1925:.
1913:10
1911:.
1905:.
1873:^
1859:.
1851:.
1839:13
1837:.
1833:.
1810:.
1800:30
1798:.
1604:.
1486:.
1478:,
1449:,
1334:.
1297:.
1045:.
930:,
918:,
914:,
806:,
790:,
786:,
782:,
702:,
698:,
672:.
630:.
614:,
610:,
606:,
591:.
579:,
567:,
442:.
398:,
390:,
386:,
358:)
354:,
350:,
323:,
270:,
266:,
262:,
229:)
225:,
221:,
134:,
122:.
98:,
94:,
86:,
82:,
78:,
70:.
6624:T
6616:T
6608:T
6600:T
6586:)
6578:h
6576:T
6572:3
6570:h
6568:T
6561:T
6503:B
6439:e
6432:t
6425:v
6377:.
6357::
6327:.
6307::
6284:.
6262::
6235:.
6215::
6192:.
6170::
6140:.
6116::
6089:.
6075::
6045:.
6021::
6013::
5986:.
5966::
5937:.
5915::
5885:.
5861::
5855:8
5834:.
5810::
5783:.
5761::
5753::
5726:.
5704::
5677:.
5657::
5649::
5626:.
5614::
5590:.
5570::
5547:.
5525::
5517::
5487:.
5465::
5438:.
5416::
5389:.
5367::
5361:3
5340:.
5316::
5289:.
5265::
5238:.
5216::
5189:.
5165::
5138:.
5124::
5097:.
5073::
5065::
5038:.
5014::
4987:.
4963::
4936:.
4914::
4906::
4876:.
4852::
4820:.
4796::
4764:.
4750::
4742::
4736:6
4715:.
4691::
4664:.
4650::
4640::
4613:.
4599::
4572:.
4550::
4513:.
4491::
4464:.
4442::
4415:.
4395::
4389:2
4366:.
4346::
4340:1
4323:.
4301::
4274:.
4254::
4228:.
4216::
4210:3
4184:.
4160::
4133:.
4121::
4098:.
4076::
4046:.
4024::
4016::
3989:.
3969::
3963:8
3945:.
3923::
3896:.
3876::
3853:.
3833::
3765:.
3741::
3714:.
3694::
3671:.
3647::
3620:.
3596::
3569:.
3547::
3539::
3507:.
3483::
3456:.
3432::
3405:.
3383::
3356:.
3334::
3304:.
3290::
3263:.
3249::
3219:.
3195::
3155:.
3133::
3106:.
3092::
3086:7
3065:.
3051::
3011:.
2987::
2957:.
2937::
2913:.
2889::
2853:.
2831::
2804:.
2782::
2774::
2747:.
2735::
2712:.
2698::
2671:.
2649::
2641::
2614:.
2592::
2565:.
2543::
2537:5
2516:.
2492::
2458:.
2444::
2417:.
2393::
2366:.
2342::
2304:.
2280::
2274:7
2253:.
2229::
2200:.
2170::
2162::
2133:.
2119::
2045:.
2025::
2017::
1989:.
1969::
1943:.
1919::
1867:.
1845::
1818:.
1806::
1279:C
217:(
201:γ
22:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.